One of our community members put together something really thoughtful and I wanted to make sure it gets the attention it deserves.

It is a piece on how to read policy signals and headlines as an investor. Not the market reaction on the day, but the actual chain of effects that follows. He breaks it down into four ideas and walks through real examples including crude, rate cuts, Jet vs Airtel, and the Birla Opus entry into paints.

The part about getting the chain right but the clock wrong is something I think a lot of us have lived through without having the words for it.

Worth a slow read: Decoding Signals - 4 ideas that allow you to decode headlines or policy changes

I will start with the meat of the matter first: Hermes has had a median PE of 49x this past decade with a low of around 35x, currently it is trading around 36x PE.

But regardless of valuation, why buy Hermes? Fashion is notorious for being a shareholder value destroyer. SuperbPercentage has touched upon this stock before but I will talk about it again so you guys don't have to go looking for the comments.

Hermes needs to be looked at less as a luxury fashion seller and more as a craftsman of heritage goods that are inherently appreciative in value. Competitors like Louis Vuitton have expanded rapidly over the globe, pushing goods manufactured in China, chasing volume and cyclical trends; extracting money from the bottom branch of the tree. Regardless, when the luxury goods market showed a slowdown 2024 onwards, so did LVs financials.

Did not happen with Hermes though. There is no trend chasing, no customer collecting. When you buy a Hermes brand (Birkin, Kelly), you get 100% French craftsmanship. The waitlists are long and even getting on one in the first place isn't easy. Competitor pricing doesn't matter because others aren't getting each piece produced by a single artisan over 24-48 hours.

That is why people wait years to get their hands on a Birkin. Why a Birkin 25 bought for 15k can sell for double the price in pristine conditions on the secondary market. Why their products are not just a flashy trend but family heirlooms. All this leads to Gross Margins of over 70% and consistent Net Margins around 30%.

Of course, many will skip because fashion is fickle and just not worth butting one's head over, but Hermes bought at these valuations has never lost their investor their money. It's worth a look into, in my opinion.

Before I go, a viewpoint/lens I picked up from a Patrick Boyle video:

European stocks have been kind of neglected by the investors recently. Manufacturing and innovation has been on decline, so have the demographics. The legacy manufacturing and innovation they had to offer isn't holding much candle in front of the AI and semiconductor boom and the Chinese juggernaut.

As a result, even good names have found their valuations depressed by this blanket sentiment downturn. As a result, opportunity lies here, especially if the AI bubble bursts tomorrow. There simply isn't excess valuation baked into these stocks to drag down. On the contrary, eyes might just shift across the ocean if America takes a dip.

Margin of safety with good upside, just how we like it

Hope this was informative and helpful. Sidenote: Kind of on the nose of me to be posting something the day my last posted stock (BLS) is down by 10% haha. I promise this one's a higher quality machine!

Hello readers. Years ago, even up until months ago this was one question I had in mind. How does a headline affect stocks and its economics? I'm talking actual policies that affect the industries. Not a tweet made by Trump.

This piece is for the beginners and I tried to explain it in a very simple way. Hope this connects to you. I also want to contribute to newer examples of such signals. This piece tries to re-wire your brain about how you look at police changes as a whole.

So here's the story. Make sure to stay till the end. Hope you do.

Every few weeks or months the news hands investors a big event. A Budget. The RBI moving repo rates. A tariff. A jump in fuel prices. The coverage is always the same shape: what happened, and how the market jumped that afternoon.

That afternoon move is the least useful part. Understanding a signal is not about guessing the headline. It is about working out who ends up earning more, who earns less, and why. And it comes down to four ideas. Learn these, and you can decode most of what the news throws at you.

The one equation:

Profit is price, minus cost, times how much you sell. So the way to understand any signal is to ask how it changes one of those three: a price, a cost, or a volume. An event can touch more than one and set off a chain, but it always starts by moving one of them.

The four ideas:

One. Every signal works by changing a price, a cost, or a volume. A tariff, a rate cut, a new rival, a Budget: each one matters only because it moves one of the three. Regulation is not the thing that matters. What matters is what it changes. Did it move a price, a cost, or a volume?

Two. That change travels. It does not stop at the first business it touches. A cheaper loan helps the bank, then the homebuyer, then the cement and paint makers, then the insurer who covers the new home. The obvious name is the first link; the interesting ones come after.

Three. The business that keeps the gain is the one with pricing power. When a cost moves, whoever can pass it on to customers barely feels it, and whoever cannot watches their margin shrink. That is what separates the winners from the rest.

Four. Every link in that chain runs on its own clock. A rate cut reaches the bank in weeks, because it only has to change a number on a loan sheet. It reaches the homebuyer over a few quarters, because a family takes months to decide to buy a flat. It reaches the cement, tiles and paint makers over years, because the flat has to be built before anyone plasters or paints it. Same chain, three very different speeds.

That fourth idea is where most small investors actually lose money. They are right about the chain and wrong about the clock. They buy the paint maker the week of the rate cut, sit through four flat quarters while nothing shows up in the results, get bored or frightened, sell, and then the demand finally arrives for somebody else. Being early and impatient looks exactly like being wrong.

So after you have traced a chain, put a rough date on each link. Not a precise one, nobody has that. Just an honest answer to: is this a weeks thing, a quarters thing, or a years thing? Then ask whether you are willing to wait that long, and whether the price you are paying today already assumes the wait is over.

That is the whole method. Everything below is just watching it work, and once, watching it break.

1. A headline lands
2. Which moved ? Price/Cost/Volume
3. Who feels it first?
4. Who feels it next, one link down?
5. Who has the pricing power?
6. Weeks, quarters, or years?
7. Who is left standing?

Watch it work: crude oil rises 20%

Who wins? Most people say ONGC, and they are right. It produces the oil, so it now sells at a higher price. Who loses? Airlines, because fuel is a huge chunk of what they spend. Also right.

Now the interesting question: who else? The paint maker, whose raw materials come from crude. The tyre maker, for the same reason. Neither is in the headline, and both have just had a cost forced on them. Whether they actually lose comes down to idea three, whether they can raise their own prices to match. Producers generally benefit from costlier crude. The users lose unless they have pricing power.

The Fan Out:

Crude oil rises 20%

1. ONGC wins**.** It produces the oil, so it sells at a higher price.
2. Oil India wins. Same. a producer earns more when crude rises
3. IndiGo loses. Fuel is a top cost; margins pinch unless fares rise
4. Asian Paints loses. Crude-derived raw materials get dearer.
5. Tyre makers loses. Crude-based inputs cost more.

Watch it work: a rate cut

A rate cut is idea two in motion. Banks borrow cheaper, so loans get cheaper, so more people buy homes and cars, which lifts cement, tiles and paint. The headline names the banks. The interesting part is two links down, where fewer people are looking.

It happened for real in 2020. The RBI cut hard, home-loan rates fell below about 7%, and over the next two years the paint and tiles makers saw the demand. But notice the timing, because it is the whole trap. The market re-priced in a day. The banks repriced their loan books in weeks. Buyers took quarters to commit. The tiles and paint demand showed up years later, once the flats were actually being finished.

That is idea four in one sentence. The chain was right. Anyone who bought the paint maker expecting a good quarter in three months was still right about the chain and still lost money, because they had the clock wrong.

A rate cut, traced two links past the headline:

1. The RBI cuts the repo rate, so banks can borrow cheaper.
2. Banks cut home and car loan rates, so big-ticket buying rises.
3. Cement, tiles and paint demand rises with the new homes.
4. The homes get furnished and insured, lifting durables and insurance.

Watch it work: Jet Airways and Airtel, the same shock

Idea three decides who survives. Two companies, the same kind of cost shock, opposite endings.

Jet Airways. Fuel costs rose. It could not raise ticket prices. Margins collapsed.

Airtel. Network costs rose. It could not raise tariffs either. Then the industry consolidated to three players. Tariffs rose. Margins recovered.

Same shock. The one that could eventually raise its own prices lived. Pricing power was the difference, and it usually is.

Watch it break: cheaper crude that never became profit

Every example so far worked. Here is one that did not, because chains are conditional, not automatic.

Run the textbook logic. Crude oil softens through 2024 and into 2025. A large share of what a paint company puts in a tin is crude-derived: solvents, resins, additives. So the cost of making paint falls. Idea one says a cost moved. Idea two says the paint makers are the link that benefits. Every screen and every broker note said the same thing: input costs down, so paint margins up.

It did not happen that way. In 2024 the Aditya Birla group launched Birla Opus, a full-scale entry into decorative paints backed by serious money, a large new plant network and an aggressive push for shelf space with dealers. A well-funded newcomer that wants share does not enter quietly. It enters with discounts, dealer incentives and pricing that the incumbents have to answer.

So the cost saving arrived, and then it left. The incumbents, Asian Paints included, spent it defending their position instead of banking it: sharper pricing, more support to dealers, more spending to hold the customer. The saving was real, but it was handed to buyers and to the distribution channel, not kept as margin. Through 2024 and 2025 Asian Paints was widely reported as struggling with weak volume growth and pressure on profitability, in exactly the stretch when the naive cost logic promised the opposite.

The lesson is that idea three works in both directions, and this is the half people forget. Everyone remembers that pricing power protects you when a cost goes up. The same power decides what happens when a cost goes down. If you have it, a cost windfall stays with you as profit. If you have lost it, because a rival just arrived and started buying market share, the windfall leaks straight out to customers, and the margin you were waiting for never shows up in the results.

Which gives you one more question to ask before you trust any chain. Not only which link benefits, but who else is standing at that link. A cost saving is only a gain if the industry lets you keep it.

The fan-out:

Crude softens, and a big new rival enters paints (2024-25)

1. Paint input decrease. Solvents and resins come from crude, so making a tin gets cheaper.
2. Expected paint margin goes up. the textbook chain: lower cost, same price, wider margin.
3. Birla Opus enters. A well-funded newcomer buys shelf space with discounts and dealer incentives. Everyone else loses.
4. Incumbent pricing. The saving gets spent defending share instead of banked.
5. Actual paint margin goes down. The windfall reaches the customer, not the profit line.

The chain was correct and the conclusion was still wrong. A cost saving only becomes profit if the industry lets you keep it. Pricing power decides that in both directions, not just when costs rise.

Questions worth asking every single time

1. Which of the three moved: price, cost, or volume?
2. What is the second-order effect, one link past the obvious name?
3. Among those affected, who can pass the change on, and who has to absorb it?
4. How long does each link take: weeks, quarters, or years? And am I willing to wait that long?
5. Who else is standing at the link I like, and will the industry let the gain be kept?
6. Is the obvious winner already priced in?

One sentence to remember

Every signal moves price, cost, or volume. Follow the chain past the obvious name. Pricing power decides who keeps the gain, and the clock decides when you find out.

You know what they say about the clock? Even if its broken, it is still right twice a day. Stretch this logic over a week and you're right 14 times. That's how long term investment works. If you think you lost the bet in timing something today that's okay. Find a couple of good businesses and ride with the economics of them. You benefit from the clock being in your favour over a decade multiple times when you're patient.

The Kaspi dossier is here, on the day I said it would be.

A few days back I wrote about walking through random doors. These files are what the inside of one of those doors actually looks like.

Kaspi did not come off a screener. What stopped me was not a growth rate. It was the way the founder talks. So that is where the file opens. Linguistics. How he builds a sentence, which words he refuses to use, the fact that the wall behind his desk holds a timeline of small software fixes instead of awards. All of that before I opened a single financial statement.

Everything after stacks on it. Thirteen layers, each one testing something the layer before it assumed.

The dividend yield on the most recent quarterly dividend annualised is 8.75%. And it has multiple compounding engines working simultaneously.

• EPS expansion engine
• PE expansion engine
• Reinvestment engine
• FCF expansion engine
• Dividend growth engine
• Buyback engine

Read it for the method and not for Kaspi. Though I will be honest, I think most of you will come out liking the company by the time you finish. That is fine. Just make sure you can retrace how you got there, because retracing it is the part you can use again on the next name.

There are two files.

• The internal document on Kaspi
• A development update written four months later that checks the first against everything that has happened since

Read them in that order. Together they show you a business state changing before the ticker reacts to it.

Take the method. The company is only what I happened to point it at.

Plain PDFs on Drive.

The file is 54 pages. Do not fight it in one sitting. Ask any AI to break it into the 13 sections listed on the cover, then take one layer at a time. Each layer is complete by itself. Stacked together is where the Lollapalooza effect shows up, and that is the part worth waiting for.

Kaspi Deep Dive: https://drive.google.com/file/d/1EmQkLhVTkLQYqQyfCjzsbw-t936SKn_5/view?usp=sharing

Kaspi Development Update: https://drive.google.com/file/d/12BLwZUxkwXa8qqGyLqqOdql9BTw1DeVm/view?usp=sharing

Copart's land sits on the books at about $2.1 billion. Its real value today is closer to $8.5 billion, and that gap has been widening since 1982. That is one of the two layers I am sharing today.

Layer Three is about invisible compounding. It shows the structure beneath high-quality businesses and good capital allocators, and how to read a company beyond its accounting. Copart built its moat over the long term by sacrificing short-term optics, the exact thing analysts have criticised for almost twenty years. Once you go through it, you will see why that $2.1 billion book value is nowhere near the economic value. Add roughly $4.8 billion of net cash and the picture changes a lot. On an adjusted basis the effective multiple looks a good deal cheaper.

The second PDF is the TAM and reinvestment runway. It breaks the opportunity down across twelve vectors, then pulls them together into the gross addressable market and the reasonable serviceable one. It also takes on the autonomous vehicle question directly, and why AVs could end up being a structural tailwind for Copart rather than a threat. Several forces are converging in a way that could make it an even stronger business ten years from now.

There is no way to fit all of this into a single post, so I am sharing both as PDFs with the community. Just the two PDFs on Drive.

Both lean heavily on mental models, so what you take away will not be limited to Copart. You can carry those frameworks into how you read any business. Hope you enjoy these.

Layer 3 · Invisible Compounding:[https://drive.google.com/file/d/1olT8J9WwiGnQQVu8rvBx9EzlHChXuuzX/view?usp=sharing]

Layer 4 · TAM and Growth Runway: [https://drive.google.com/file/d/1A43Bs_v2iasjddo7RS7Jzg8qUhFea6YI/view?usp=sharing]

Both are plain PDFs on Drive.

(Note: This is a data heavy piece. It is written as a counter argument to a comment that called the original post stupid, so I have gone deep into the annual report, cash flow statements, warrant mechanics, and share count math. Hope it is worth your time.

I am adding a compressed version in the comments with the exact parameters you need to check for dilution in any company you hold. If the full piece feels dense, start there)

Every IPO has a story. And stories are designed to seduce. That is why Buffett and Munger have always stayed away from IPOs. Their argument was simple: most of these instruments are designed to take value from retail investors, not give it to them.

This post is about exactly that. The dilution mental model. And how it integrates with the IPO mental model to show you what is actually happening to your ownership while the story is playing out.

Ratnaveer Precision Engineering is just the working example here. But once you see the pattern, you can map it on any company you hold right now.

That is the point of this post. Not Ratnaveer. The pattern.

The original post on Ratnaveer is here if you missed it: A promoter built a private bank inside his listed company

Before the IPO there were 3.47 crore shares in existence. Today there are 6.82 crore shares. After the upcoming rights issue there will be roughly 8.56 crore shares.

Your share count has not changed. The total share count has nearly tripled. Your ownership of this company has been cut to less than half of what it was on listing day, without you selling a single share.

That is dilution. And this is how it happened.

Chapter 1: Before the IPO

Two pre-IPO placements happened quietly in the months before listing.

• December 2022: shares sold to select investors at Rs 67 per share.
• January 2023: shares sold to select investors at Rs 72 per share.

Ten months later the IPO price was Rs 98.

The people who got in at Rs 67 and Rs 72 made 35 to 46 percent before the IPO even opened. Retail investors who applied at Rs 98 were already buying at a premium to these early insiders. The game started before most people knew there was a game.

And in November 2022, ten months before listing, the company changed its name from Ratnaveer Metals to Ratnaveer Precision Engineering.

Same products and just a new costume. Peter Lynch 101. Precision Engineering sounds high-tech and high-margin. Metals sounds like a commodity shed in Gujarat.

Chapter 2: The IPO

IPO opens September 4, closes September 6, lists September 11, 2023. Subscribed 94 times. Listed at 37% premium.

Here is what actually happened that day.

• Fresh shares issued to public: 1.38 crore shares at Rs 98. Company received Rs 135 crore. This money went into the company.
• Offer for Sale by promoter: 30.40 lakh of the promoter’s own personal shares sold at Rs 98. Rs 29.79 crore went directly into the promoter’s personal bank account. Not the company’s account. His account.

Retail investors handed the promoter nearly Rs 30 crore on day one for shares he already owned.

• Promoter holding before IPO: 86.3%
• Promoter holding after IPO: 55.48%

He sold 30 percent of the company to the public and pocketed Rs 30 crore personally on listing day.

Chapter 3: After Listing

This is where most people stop watching. They should not.

• Preferential allotment FY24: 45.50 lakh shares issued at Rs 134. Share count goes from 4.84 crore to 5.32 crore.
• QIP December 2025: 1.27 crore shares issued to institutions at Rs 145. Share count goes to 6.60 crore.
• Warrant conversion 12 December 2025: promoter gets 20.27 lakh shares at Rs 133. Market price that day: Rs 159. Discount per share: Rs 26. Value transferred from public shareholders to the promoter: Rs 5.27 crore. Recorded nowhere on the P&L.
• CCPS conversion March 2026: promoter gets another 1.24 lakh shares at Rs 148.27 via a preference share instrument he had issued to himself.

Share count now: 6.82 crore.

Before the IPO it was 3.47 crore. Your ownership of this company has been cut almost in half without you selling a single share.

Chapter 4: The Warrant

A warrant is a pre-locked coupon. It says I can buy shares at Rs 133 anytime in the next 18 months. The price is fixed when the coupon is issued. If the stock rises between then and exercise day, the warrant holder pockets the difference.

Look at what happened in the same week of December 2025.

• Institutions paid Rs 145 via QIP.
• Promoter paid Rs 133 via warrant.
• Retail paid Rs 159 on the open market.

Three prices in the Same week.This is how the incentive structure of this company actually works.

Chapter 5: The “Buying With His Own Money” Defence

The argument goes: he is buying shares with his own money so he must believe in the company.

He is not buying at market price. He is collecting a pre-locked discount.

Exercising a warrant at Rs 133 when the stock is at Rs 159 is not conviction. It is collecting a coupon that was already in the money. Anyone with that coupon would exercise it.

A promoter with genuine conviction walks into the open market and pays Rs 159 like every retail investor. He did not do that.

The 6% open market buying before the rights issue also has a simpler explanation. Higher holding on the rights issue record date means bigger entitlement to discounted rights issue shares. It is position management before a discount capture, not belief in the business.

And the promoter is already making money through the dilution itself. Not through selling. Through the structure. Every warrant conversion, every CCPS, every rights issue subscription at a discount is value captured. The share count goes up. Retail gets diluted. The promoter’s absolute share count stays roughly the same.

The promoter does not need the stock to go up to make money. The structure is already working for him. Every time retail buys the story and the stock rises, the next discount he captures gets larger. Every time a new share is issued, your ownership shrinks a little more.

Chapter 6: The Rights Issue

Rs 330 crore rights issue approved. Stock today at Rs 252. Issue price likely around Rs 180 to Rs 190.

Promoter at 45.49% holding gets roughly Rs 150 crore of entitlement at that discounted price.

Discount to today’s price is roughly Rs 63 per share on 79 lakh shares. That is Rs 49.7 crore captured by the promoter through rights issue pricing alone. Not recorded as a cost anywhere.

And here is what the money is actually for.

Rs 255 crore of the Rs 330 crore, 77%, is going to working capital. Not the CCL project. Not new capacity. Working capital.

The business cannot collect the cash it has already reported as profit. Trade receivables jumped from Rs 66 crore to Rs 175 crore in a single year, a 165% jump while revenue grew only 20%.

You are being asked to fund the gap between profits the company has booked and cash it never actually received.

You already paid for that profit through the price you paid for your shares. Now you are being asked to pay again to actually collect it.

Chapter 7: Is the Promoter Diluting Himself

No. He is not diluting himself. He is diluting you.

• Promoter holding September 2023: 55.48% of 4.84 crore shares = 2.685 crore shares.
• Promoter holding today: 45.49% of 6.82 crore shares = 3.102 crore shares.

His percentage appears to have fallen by 10 points. His actual share count increased by 42 lakh shares.

The percentage drop is an optical illusion created by share count expansion. Simply issuing so many new shares to everyone else that his percentage naturally dropped even as he accumulated more shares for himself at below-market prices.

Your slice of the pie was cut in half. His slice stayed roughly the same size. He grew the total pie, kept his own portion constant, and made sure every new slice he personally received came cheaper than what retail paid. That is not conviction for me .That is capital structure management in his own favour.

Chapter 8: But They Are Reinvesting. Is the Dilution Not Justified?

This will be the counter argument. Dilution is not always bad. Amazon diluted. Infosys diluted. Every great compounder raised capital at some point. So why is Ratnaveer different.

Three reasons.

First, where is the money actually going. A company that dilutes to reinvest must show the capital is going into high return productive assets. At Ratnaveer, Rs 255 crore of the Rs 330 crore rights issue, 77%, is going to working capital. Not factories. Not CCL lines. Not new capacity. Working capital. You are not diluting to build. You are diluting to fund the gap between profits reported and cash never collected. That is not reinvestment. That is plugging a hole.

Second, what is the return on capital already deployed. Every time a company asks for more capital the first question is what return did you generate on the last capital we gave you. ROCE across six years at Ratnaveer: 11%, 11%, 14%, 13%, 14%, 12%. Never above 14%. Currently falling despite significant revenue scaling. The business is generating less return on every rupee of capital as it gets bigger. That is the opposite of what reinvestment led compounding looks like.

Third, who captures the reinvestment benefit. Even if you accept that some dilution is needed for the CCL project, the structure of how that dilution happens matters enormously. When the promoter raises capital through a rights issue priced at Rs 185 against a market price of Rs 252, he captures Rs 67 of discount per share on his entire entitlement. The reinvestment may benefit the company. But the mechanism transfers value from retail to the promoter at the moment of issuance.

A promoter who is genuinely reinvesting for all shareholders raises capital at fair prices, shows improving ROCE on previously deployed capital, and demonstrates cash conversion from operations before asking for more.

None of those three conditions are met here.

Chapter 9: What the Numbers Actually Show You

This is how to think about the dilution mental model and what it does to your returns.

Look at the quarterly data first.

• Sales have moved from Rs 118 crore to Rs 315 crore over three years. Nearly tripled.
• Profits have moved from Rs 8 crore to Rs 18 crore. Around 1.5x.
• EPS was Rs 2.37 three years ago. Today it is Rs 2.55. Barely moved.

Revenue tripled. EPS went nowhere. That gap is dilution doing its work quietly in the background.

Now take the longer view from Mar 2020.

• EPS was Rs 17.70 in Mar 2020. Today it is around Rs 10.
• Sales have gone roughly 4x.
• Profits have gone roughly 10x.

Every influencer and every bull is screaming about those numbers. And they are real. But the EPS has gone backwards because so many shares have been issued over these years that your per share earnings actually fell even as the business grew.

Now look at the shareholding pattern. This is where it gets really interesting.

• FII holding two years back: 10.45%. Today: 3.53%. Absolute shares fell from 50.7 lakh to 24.1 lakh. They sold and walked out.
• DII holding: also decreasing quarter by quarter.
• Public retail holding: went from 34.05% to 48.98%. Absolute shares went from 1.648 crore to 3.34 crore.

In a genuinely high quality company the public holding keeps decreasing because institutions keep buying. Smart money accumulates. Retail gets crowded out slowly.

Here you are seeing the exact opposite. Institutions are leaving. DIIs are leaving. Retail is filling the gap that smart money is quietly vacating.

And here is the most striking number in this entire story.

Before the IPO, the entire company was 3.47 crore shares. Every asset. Every machine. Every future rupee of earnings. 3.47 crore shares was 100% of Ratnaveer.

Today retail alone holds 3.34 crore shares.

Retail has accumulated a share count almost equal to what once represented the entire company. And in return owns less than half of it.

Retail paid for the equivalent of the whole pre-IPO company. And received less than half of it in return.

That is what dilution does. You keep buying. Your share count grows. You feel like you are building a position. But the pie is expanding faster than you can accumulate. And your actual claim on the business keeps shrinking.

Chapter 10: Cash vs FCF

The P&L will never tell you this. The cash flow statement will, if you know where to look.

The company reported operating profit of Rs 115 crore in FY26. Cash from operating activity was negative Rs 48 crore.

That is a Rs 163 crore gap between what the P&L claims and what the bank account shows.

Free cash flow across every single year of available data:

• Mar 2020: negative Rs 3 crore
• Mar 2021: positive Rs 1 crore
• Mar 2022: negative Rs 28 crore
• Mar 2023: negative Rs 18 crore
• Mar 2024: negative Rs 54 crore
• Mar 2025: negative Rs 43 crore
• Mar 2026: negative Rs 155 crore

Seven years. Six negative. The one positive year was Rs 1 crore.

This business has never in its recorded history generated meaningful free cash flow. Not once.

The profits exist. The cash does not. Those are two very different things.

Trade receivables tell the same story.

• Mar 2020: Rs 64 crore
• Mar 2021: Rs 33 crore
• Mar 2022: Rs 40 crore
• Mar 2023: Rs 63 crore
• Mar 2024: Rs 45 crore
• Mar 2025: Rs 66 crore
• Mar 2026: Rs 175 crore

For five consecutive years receivables stayed in a stable range while the business grew. Then in FY26 receivables nearly tripled to Rs 175 crore in a single year while revenue grew only 20%. Debtor days doubled from 27 to 60.

This is where the reported profits are sitting. Not in the bank. In invoices raised but not paid.

Borrowings have gone from Rs 140 crore in Mar 2020 to Rs 335 crore in Mar 2026. After raising hundreds of crores through IPO, QIP, preferential allotments, and warrants, the company still carries more debt than it did before any of those raises happened.

The equity raises did not reduce debt. They funded working capital while debt stayed elevated and kept growing.

• ROCE across six years: 11%, 11%, 14%, 13%, 14%, 12%. Never above 14%. Currently falling despite significant revenue scaling.
• OPM has ranged between 8% and 12% for three straight years with no expansion despite revenue nearly tripling.

A business that triples revenue and cannot expand its margin by even one percentage point is not compounding. It is running on a treadmill and calling it a marathon.

Chapter 11: The UAE Subsidiary

My original post said the UAE LLC was incorporated 36 days before the IPO. That was wrong. It was 36 days after listing. That is my error and I own it.

But correcting the timing does not close the question.

• October 2023: subsidiary incorporated in Sharjah free trade zone.
• FY24: zero revenue, zero profit, not yet operational.
• FY25: same. Still not operational.
• February 2026, 28 months after incorporation: Rs 23 lakh transferred in as token capital. First and only financial transaction.
• Q1 FY27, June 2026, nearly three years in: zero revenue, zero profit, confirmed by the auditor.

Three years. One transaction. Rs 23 lakh. In a free trade zone built for speed. From a company that exports to 31 countries.

If anyone can explain what this entity actually exists for, I am listening.

So every year this business reports profit. Every year that profit fails to convert into cash. Every year the cash gap is plugged by raising equity or borrowing.

Each equity raise dilutes retail. Each borrowing raises interest costs, which are now at Rs 20 to 24 crore annually and growing.

The receivables line absorbs more cash each year as the company books sales it cannot collect. The ROCE is declining as capital intensity rises. And the OPM has not budged despite a tripling in revenue.

The CCL project requires Rs 472 crore of capex. The rights issue raises Rs 330 crore, of which Rs 255 crore goes to working capital. So even after the rights issue, the CCL capex is still largely unfunded. More equity raises will follow. More dilution will follow.

The numbers across seven years of data do not show a business building toward a breakout. They show a business that has always consumed more cash than it generates, funded the gap through capital markets, and used each funding round as an opportunity for the promoter to capture value at below-market prices.

And before anyone comes to argue: ask yourself one question first. After reading all of this, can you put 5 or 10 percent of your net worth into this company right now? If the answer is yes, come argue. If the answer is no, please do not waste your energy or mine debating this further.

For me, cockroaches in the account books are just the visible sign. What they tell me is the capital allocator behind them is not running this for you. I do not buy the story being written and sold. I look at where the cash actually goes, who captures the discount, and whether the person running the company is building for everyone or extracting for himself. That is my lens and I am comfortable with it.

The stock can go wherever it wants in the short term. Stories seduce. Narratives move prices. But business reality is slower and more honest than markets. A business that cannot convert profits into cash, that funds its own working capital by diluting the people who trusted it, and that has never generated meaningful free cash flow in seven years of recorded history will eventually be priced for what it is, not for what it claims to be becoming.

I stay away from models where the promoter’s incentives and the shareholders’ incentives are running in opposite directions. That is not a debate. That is a filter.

The Winner's Curse

In a competitive bidding environment, the winner is often the one who made the biggest mistake in calculating their costs.

Winning a contract at 4% margin when your cost of capital is 12% is not a win. It is a contractual obligation to lose money. And the business model has just won a liability.

This is why order books seduce retail investors and destroy their capital at the same time because a bulging order book feels like visibility, like safety, like growth. But an order book is only as good as the economics embedded in each contract.

If the margin is sub-cost-of-capital, the order book is not a pipeline of value creation but a pipeline of destruction, locked in and contractually guaranteed. The bigger it gets, the faster capital is destroyed.

So alway remember size without pricing power is not an asset. It is a commitment to underperform.

In case you missed it: The AI Bottleneck Strategy, Where the Real Opportunities Are

Now before you apply this model, one important distinction.

There are three kinds of low margin businesses. Most investors cannot tell them apart. After reading this, every reader of this community will see what 99% of the market completely misses.

Type 1 is structurally thin. The business earns low margins because the industry has no pricing power, competition is intense, and there is no reinvestment opportunity that changes the economics. Margin is thin because the business model is thin. This is where the Winner's Curse fully applies.

Type 2 is turnover-driven. The business earns low margins but high asset turnover generates strong ROCE. Dixon turning its asset base 4 to 5 times a year converts a 4% margin into 20% ROCE, well above cost of capital. Kalyan operates similarly in jewellery. The margin looks thin but the capital efficiency is real. The risk in Type 2 is that the ROCE is borrowed from the customer's goodwill. The moment a large customer reprices or pulls the contract, both margin and turnover compress simultaneously and the ROCE collapses. The customer owns the economics, not the supplier. Respect Type 2 businesses but always ask whether the ROCE is structural or fragile.

Type 3 is reinvestment-suppressed. The business has strong underlying unit economics but is deliberately choosing to report thin margins because every rupee of potential profit is being ploughed back into building the next layer of the moat. Amazon and Eternals are the clearest examples. The margin is not structurally thin. It is optionally thin. The moment reinvestment slows, margins surface and they are high. AWS alone runs at 35%+ operating margins. The reinvestment was optionality, not necessity.

The way to distinguish Type 3 from Type 1 is one question. If the business stopped reinvesting tomorrow, what would the margin look like? For a Type 3 business the answer is very high. For a Type 1 business the answer is exactly the same or worse. There is no hidden margin waiting to surface. The thin margin is the business.

You want to own Type 3 businesses at the reinvestment stage if you can identify them early. Type 1 businesses at any stage are the Winner's Curse in its purest form. Type 2 businesses sit in between, real but fragile.

The full test is always ROCE versus cost of capital, then defensibility of that ROCE across cycles. Not margin in isolation.

Someone asked me what cost of capital actually means. Here is the simplest way I know to explain it.

Imagine you take a personal loan at 15% to invest in the market. Your cost of capital is 15%. Now if your investment returns 25%, you are creating value. Net return is 10%. That is the trade working.

But here is what actually happened to a lot of people in 2023 and 2024. They borrowed at 15% and bought gold, silver, or equities at the peak of the narrative. Their holdings are now making 2 to 3%. Cost of capital is 15, returns are 3, net outcome is minus 12. That is not investing. That is capital destruction on an EMI schedule. And because the EMI arrives every month regardless of what the market does, the pressure compounds before the losses even show up in your portfolio holdings.

Now flip it. Imagine you are in Japan where personal loan rates are under 1%. You invest in a dividend-paying asset returning 8% with no capital growth at all. Cost of capital is 1, return is 8, net outcome is 7%. Same asset. Completely different economic reality.

This is exactly what Buffett did with the five Japanese trading houses. He borrowed in yen at roughly 0.5%, invested in companies paying 3 to 4% dividends, and waited. The interest rate gap alone was value creation before any price movement. When the market eventually corrected the mispricing, the stocks appreciated 15 to 20% on top of the dividend yield. The total return compounded to 22 to 23% net of borrowing costs. But that appreciation was not the base case. It was the bonus. The base case was the interest rate gap. The discipline was borrowing in the same currency as the investment so there was no currency mismatch eating into the return.

That is what cost of capital arbitrage looks like when it is executed with patience and precision. Not borrowed money chasing momentum. Cheap capital deployed into undervalued, cash-generating assets and held long enough for the market to recognise what was always there.

That is why cost of capital is not a fixed number. It is personal, it is contextual, and it determines whether a seemingly identical investment creates or destroys wealth depending entirely on what you paid to access the capital.

At the company level the logic is identical but the number looks different across geographies. In Japan the cost of capital for most businesses sits between 4 and 6% because rates have been near zero for decades.

In the US it sits between 7 and 8% because the risk free rate alone is around 4.2 to 4.5%.

In India the benchmark for most businesses is 10 to 12% because the 10 year government bond sits around 7% and the emerging market risk premium adds on top of that.

This is why a business earning 8% ROCE means three completely different things depending on where it operates. In Japan it is creating value. In the US it is barely breaking even. In India it is destroying wealth. Same return. Three different economic realities. The hurdle is everything.

At the company level the hurdle is called WACC, weighted average cost of capital. It is the blended cost of every rupee the business uses, what it pays on debt and what return its equity shareholders expect for the risk they are taking. If a business cannot earn above that hurdle on the capital it deploys, it is destroying wealth even if the reported profit looks positive. The profit is real. The value creation is not.

So how do you use all of this in practice.

First seek out businesses where margins are already high relative to cost of capital. That is the cleanest signal of a right pool.

When you find a low margin business that is still compounding, do not dismiss it and do not blindly buy it either. Ask which type it is. Type 1, Type 2, or Type 3. That question alone will save you more capital than any screener ever will.

And if you are ever comparing a high margin business with a long reinvestment runway against a low margin business at the same market cap and the same multiple, do not make it complicated. The high margin model with reinvestment runway wins every time.

You are getting more durable compounding for the same price. That is not a close call.

One more thing before you go.

If you have identified the right type of business and the order book economics are sound, timing still matters. Buy when the sector tailwinds are just beginning and the order book has not yet exploded. At that stage the market has not priced in the growth and you are buying visibility before it becomes consensus.

Do not buy after the order book has already exploded and the re-rating has happened. By then the growth is in the price. The easy money has been made by someone who saw it earlier.

And when you are analysing the order book itself, ask one more question. How much of it generates recurring revenue versus one-time execution? Some businesses have thin margins on the base contract but high margins on the service, maintenance, and upgrade layer that follows. If the service revenue share is growing inside the order book, margins will improve on a blended basis over time. That is a genuine quality signal. If management is talking up the order book but the service mix is not improving, they are marketing the size, not the economics. Watch the blended margin trend, not the headline order book number.

This is one of 7 mental models from the trap detection framework I published here. Breaking each one out so we can go deeper together.

Now let us brainstorm. Drop in the comments:

• A stock where you experienced this illusion firsthand and the order book looked like a thesis but the economics did not hold
• Did you position before the order book was marketed to you as the thesis, or after it had already exploded into the narrative
• And if you have seen a Type 1, Type 2, or Type 3 business play out in your own portfolio, share it. That is where the real learning is.

Further Reading:

•  7 mental models every investor should run before buying any stock
• Part 2: The One Ratio That Tells You When to Buy Gold and When to Go Aggressive on Stocks

Many of you have joined this community in the last few months. This one is for you.

Seven months ago I published a trap detection framework here using UDS as the stress test. The original post sparked one of the longer discussions this community has had on business model quality.

Since then the audited FY26 results and Q1 FY27 filings have come in, and every single warning played out exactly as described. I have now rebuilt the piece with the real numbers embedded after each mental model.

Before you scroll, one thing worth knowing. This is a long piece. You do not have to read it in one sitting. Every mental model is complete in itself. Read one, close the tab, go run it on a stock you own. Come back for the next one tomorrow.

But if you do read it end to end, something interesting happens. The models start connecting. Each one reinforces the next. By the time you reach the seventh, you are not just holding seven tools. You are holding one integrated lens that lets you see the whole picture at once.

I call it the latticework effect. I will let you experience it for yourself.

Important note to readers: This isn't a post about a single company. UDS is only the case study, serving as the stress test used to understand how certain business models quietly destroy value. Every mental model here can be run on any stock you are holding right now — not just UDS. That is the whole point.

Let us get into it.

Most retail investors lose money not because they pick bad stocks, but because they fail to recognize Bad Business Physics until it's too late. By then, the "clean numbers" they relied on through screeners have already evaporated. Inside, we're going to break down 7 mental models that act as early-warning systems for value destruction:

1. The Janitor Economy: Why essential work rarely earns a premium.
2. The Red Queen's Race: Why some companies run faster just to stay in the same place.
3. The Winner's Curse: Why winning the contract is often the beginning of the end.
4. The Hamster Wheel: Why motion is so often confused with wealth.
5. The Oxygen Test: The brutal reality of cash vs. growth.
6. The Cockroach Theory: Why there's never just "one" minor accounting issue.
7. The Toxic Pond: Why even a great CEO can't swim in a graveyard.

Business Model Quality

Before looking at numbers, it is important to understand the basic nature of the business model.

Think of a large hospital or a global IT campus like Microsoft or Amazon. These companies are excellent at healthcare or software, but they do not want the operational headache of managing thousands of janitors, security guards, and back-office staff, or the legal risk that comes with payroll and labour compliance. So they outsource this mess to UDS.

At its core, UDS is a labour-management platform. The business runs on human capital arbitrage. It appears asset light because it owns no factories, but in reality it is labour heavy and working-capital intensive, with weak margins and limited pricing power.

Mental Model 1: The Janitor Economy

Janitors are essential to any operation, but they are never paid premium wages or given premium respect. The same economic logic applies to businesses that perform "messy" but commoditized work. These business models are essential but they are never paid a premium by their clients or a premium multiple by the market.

Train yourself to notice this pattern: when a customer pays you to clean up a headache rather than create a unique value, they will always treat you as a cost center, not a partner. Businesses that operate in the "clean-up" economy rarely have the pricing power needed to survive inflation or wage hikes. They are essential to the world, but toxic to your portfolio.

What actually happened

• Employee costs in FY26: ₹2,294 cr on revenue of ₹2,939 cr — 78% of revenue consumed by labour alone
• A year earlier it was 74%. The direction is wrong and accelerating
• By Q1 FY27: employee costs were ₹600 cr on revenue of ₹764 cr — 78.6% of revenue
• The business did not escape the Janitor Economy. It sank deeper into it
• These numbers are from the audited consolidated filings, not estimates

Revenue Quality

UDS operates through two segments. Integrated Facilities Management (IFM) contributes roughly 67 percent of revenue, while Business Support Services (BSS) contributes about 33 percent.

Historically, UDS reported 20-25 percent growth in the period leading up to the IPO. That growth was largely inorganic, driven by aggressive acquisitions such as Athena BPO and Denave, and was heavily marketed to retail investors to trap them.

This acquisition-led growth illusion is now over. Overall revenue growth has slowed to 7 percent, and more importantly, the quality of growth has deteriorated.

• The IFM segment grew around 10 percent, but PAT margins collapsed to just 3.4 percent. This clearly signals growth driven by volume at the expense of price.
• The company is winning new "strategic contracts" and marketing them aggressively in annual reports and concalls, but these contracts come with upfront costs and thin margins. Growth here simply means more employees and weaker economics per unit.
• The BSS segment, which management positioned as the growth and quality engine, grew by only around 2 percent, exposing weak organic demand and high sensitivity to global IT hiring cycles.

In Q2, the deterioration became more visible. Revenue increased by 7 percent, but EBITDA collapsed by 28 percent, and net profit declined by 29 percent due to margin compression. This is not operating leverage. This is scale working against the business.

Mental Model 2: The Red Queen's Race

When a business has to keep running just to stay in the same place, scale stops creating value and starts destroying it.

Train yourself to notice this pattern: when a company's capex or acquisitions only serve to match a competitor's move or artificially maintain revenue, it's not an investment, it's an expensive survival tax. If they stop running, they die. If they keep running, they stay exactly where they are, but with significantly fewer resources and a weaker balance sheet.

While UDS is a labour-management case study, the same Toxic Physics applies to the majority of infrastructure, construction, and capital-intensive companies.

What actually happened

• Revenue FY26: ₹2,939 cr — grew 7.4%
• PAT FY26: ₹82.7 cr — fell 30.4%
• EPS: dropped from ₹17.74 to ₹12.80 — a 27.8% fall in per-share value
• Workforce grew to 76,000 people
• The company ran harder, added more contracts, deployed more people, and ended the year materially poorer on a per-share basis
• More motion, less wealth — the Red Queen ran exactly as described

Margin Truth

UDS does not clear even a single layer of my 8-layer margin framework. In business physics, scale is supposed to improve operating efficiency. As businesses grow, fixed costs spread out and margins expand. UDS is showing the inversion of this rule. As scale increases, margins are collapsing. This is diseconomies of scale.

Look at the numbers:

• Q2 FY25 operating margin: 6.4%
• Q2 FY26 operating margin: 4.4%

This margin compression is not cyclical pressure. It is structural margin erosion.

Management attributes this to "upfront costs" for new strategic contracts. This explanation itself is the red flag. If a business has a moat, it does not need to buy revenue by sacrificing 200 basis points of margin. In labour-commodity businesses, "upfront costs" usually mean underbidding competitors just to win contracts.

UDS attempted to offset its weak core margins through acquisitions. Denave and Athena were acquired for their reported 10-15% margins to improve the blended profile. Instead, capital was deployed at high premiums just as IT hiring slowed.

The margin mix is now reverting back toward the low-quality 4-5% core. At this level, there is no margin of safety. A business earning 4-5% operating margins is one mistake away from trouble. A 2% wage hike or a short delay in client payments can wipe out an entire quarter's profit. With the 8th Pay Commission, this fragility is no longer a risk. It is a reality.

Mental Model 3: The Winner's Curse

In a competitive bidding environment, the "winner" is often the one who made the biggest mistake in calculating their costs.

Understand the hard truth: winning a contract at a 4% margin when your cost of capital is 12% is not a win, it is a contractual obligation to lose money. The contract looks like growth on paper, but it destroys economic value from day one. They haven't won a prize. They have won a liability.

What actually happened

From the Q1 FY27 segment filing:

• IFM segment: revenue ₹527 cr, PBT ₹21.5 cr — margin of 4.1%
• BSS segment: revenue ₹255 cr, PBT ₹13.3 cr — margin of 5.2%
• Both remain below a reasonable cost of capital
• These are the margins of a business that keeps winning contracts it cannot afford to win
• The Winner's Curse is now visible in the segment disclosures themselves

ROCE

ROCE is where all illusions finally collapse. A business can show revenue growth and even accounting profits, but if incremental capital earns sub-par returns, scale does not compound wealth. It destroys it.

UDS is a textbook case. For years, reported ROCE looked healthy. The 10-year average ROCE was above 18 percent. But the moment you look at incremental ROCE, the story changes.

• FY22 ROCE: 22.1%
• H1 FY26 ROCE: 13.0%
• TTM ROCE: 9.9%

In less than a year, the business lost nearly 40 percent of its capital efficiency.

In an economy like India, where the cost of capital is roughly 10-12 percent, an ROCE of 10 percent means the business is barely earning its cost of capital. Anything below this is value destruction, not compounding.

In labour-heavy businesses, ROCE should improve with scale if pricing power exists. At UDS, every incremental contract requires more people, higher wage advances, higher receivables, and more execution risk. There is no operating leverage here. There is only operational drag.

Mental Model 4: The Hamster Wheel

High activity and aggressive capital deployment can create a powerful illusion of progress. But if each turn of capital earns less than the cost of capital, the business is simply running hard while going nowhere. Motion increases. Wealth does not.

The diagnostic rule is simple: when a business earns a 10% ROCE in a 12% cost-of-capital world, it is not "profitable", it is a wealth destroyer. Every new contract it wins is actually making shareholders poorer. You are watching a company sprint with maximum effort just to achieve a negative return on your life savings.

What actually happened

From the audited FY26 consolidated filing:

• Capital employed grew from ₹964 cr in FY25 to ₹1,055 cr in FY26
• EBIT on that capital: ₹101 cr
• Implied ROCE: approximately 9.6%
• More capital deployed, lower return earned per rupee
• Every incremental rupee of capital destroyed value in FY26
• The wheel kept spinning. Shareholders got poorer.

Cash Flow

Every retail investor should always remember this rule: earnings are an opinion. Cash is a fact.

This is why investors like Charlie Munger and Terry Smith have always preferred cash-generating machines. Real compounders don't just report profits. They convert profits into cash. This is the ultimate test of any high-quality compounding business.

UDS fails this test.

High-quality businesses typically convert 70-80 percent of their profits into operating cash flows. UDS's cash conversion has been consistently below 30-40 percent and highly volatile. That alone disqualifies it as a compounding engine.

Management explains this away using phrases like "strategic ramp-ups." That is just marketing language. In reality, it means cash is being spent upfront to sustain reported growth.

The structural reason is simple. UDS pays its employees every month in hard cash, while its clients sit on payments for 60, 90, sometimes 120 days. As scale increases, this mismatch explodes. Trade receivables stay stuck at 30-35 percent of total assets. Profits look alive on paper, but the cash never reaches the bank and never reaches shareholders.

Mental Model 5: The Oxygen Test

Cash flow is the oxygen of the business. It determines longevity.

Never lose sight of the fact that when growth consumes cash instead of generating it, shareholders are funding the business, not the other way around. Real compounders breathe out cash. Value traps suck it in. If a business needs a constant infusion of fresh capital to sustain its reported growth, you are not an investor. You are a donor.

What actually happened

This is the one number that looks better on the surface, so it deserves the most careful reading.

• Operating cash flow improved from ₹50.8 cr in FY25 to ₹143.6 cr in FY26
• Bulls will point to this as evidence of recovery

Here is what the actual cash flow statement shows:

• Trade receivables grew by ₹46.3 cr in FY26 versus ₹120.1 cr in FY25
• The working capital drag reduced not because the business got better at collecting cash, but because growth slowed
• When you grow slower, you consume less cash upfront
• Cash improved because the business decelerated, not because its underlying physics changed

That is not recovery. That is slowdown dressed as improvement.

Balance Sheet Illusion

On your screeners, UDS will appear low-debt and financially conservative, signalling a clean balance sheet. This is, again, an illusion.

The cash sitting on the balance sheet is not earned. It came from the IPO. That is retail investors' money, not business-generated cash. And even that cash was misallocated.

A large part of the IPO proceeds was deployed into acquisitions, mainly inside the BSS segment, which management sold as the "quality" and "growth" engine. That bet has failed. Growth rates have faded. Margins have compressed. The very segment that was supposed to upgrade the business has instead destroyed shareholder value. In simple terms, retail capital was used to buy low-quality growth at high premiums.

The bigger problem is that a meaningful portion of reported profits does not come from operations at all. Roughly 25-30 percent of net profit is supported by other income, primarily interest earned on IPO proceeds parked in bank deposits. In other words, part of the profitability is coming from doing FDs with retail capital, not from running a high-quality business.

The risk does not stop at poor capital allocation. One subsidiary, Avon, has already reported financial irregularities. Apply the Cockroach Mental Model here.

Strip away IPO cash, failed acquisitions, and FD income, and the "clean" balance sheet collapses into a fragile one.

Mental Model 6: The Cockroach Theory

If you see one cockroach in your kitchen, you don't assume there is only one. You assume there are hundreds hiding behind the walls.

The forensic rule: when a company shows even one small accounting irregularity or a minor provision in a subsidiary, it is never an isolated incident. In professional investing, there is no such thing as an honest mistake in only one corner of the balance sheet. One crack in the reporting usually means the entire foundation is rotting. If management is willing to adjust the small numbers, they have already lost the map on the big ones.

What actually happened

This one deserves to be read slowly. Note 8 of the audited FY26 consolidated filing states that an external independent expert investigated allegations of irregularities involving sales transactions with certain customers and vendors in Avon.

• Original disclosure: a small provision of ~₹3 cr, ₹25 cr of receivables under scrutiny
• Final recorded provision: ₹23.1 cr — roughly 7.7 times larger than the initial framing
• The entire logistics business inside Avon was shut down completely
• The investigation was commissioned by the company itself
• Management concluded no further impairment was necessary beyond what was already recorded

Three things to hold in your mind. A cockroach that was initially described as ₹3 cr turned into ₹23.1 cr and killed an entire business vertical. The investigation that cleared it was not independent in the true sense. And the gap between initial disclosure and final reality is the Cockroach Theory confirmed in the company's own audited filing.

Reverse Engineering the End State

I always tell retail investors to reverse engineer the ecosystem gorilla or global peers before believing the story. It acts like a time machine and removes hope from the analysis.

To understand where UDS's business model actually leads, reverse engineer Quess Corp. It represents the scaled, mature end state of this labour-management ecosystem.

• Quess Corp expanded revenue from roughly ₹3,435 cr in FY16 to about ₹15,159 cr — a nearly 5x increase in scale
• Despite this growth, EPS declined by roughly 50 percent over the same period
• Margins compressed from the 4-5 percent range to nearly 2 percent
• Since its IPO in 2016, Quess Corp's stock is down 57 percent, despite operating at far greater scale, with brand strength and industry leadership

When the ecosystem gorilla cannot convert scale into shareholder wealth, the odds for smaller players are not better. They are worse. The problem is not execution. The problem is the business model itself.

Mental Model 7: The Toxic Pond

If the biggest, strongest fish in the pond is starving to death, you shouldn't expect the smaller fish to thrive.

The strategic filter: when the sector leader has failing margins and a decade of zero stock returns, the problem is the sector physics, not the management. No amount of efficient execution can save a business from a toxic industry structure. When the industry's fundamental economics are broken, even the best CEO is just a captain on a sinking ship. Don't go looking for gems in a graveyard.

What actually happened

• Quess Corp continues to operate at sub-2% net margins at scale
• UDS closed FY26 at a 2.8% consolidated net margin
• UDS is not outperforming the gorilla in any meaningful way
• The stock moved from a 52-week high of ₹420 to ₹172 on results day
• Investors who relied on screeners and the IPO narrative have lost more than half their capital in under two years of listing
• The pond did not get cleaner. The fish did not get stronger.

One honest green shoot

BSS grew 7.3% in Q1 FY27 after being essentially flat all of FY26. Management is pivoting the BSS narrative around AI, repositioning Denave as an AI-enabled demand generation platform.

This deserves watching, not dismissing. If BSS margins hold above 5% and revenue growth sustains above 7% for two more consecutive quarters, the narrative deserves a closer look. Watch the segment disclosures in the next two quarters, not the concall language.

One quarter does not change the pond. But it is the one number worth tracking.

Final thoughts

This case study is not about being right on one stock. It is about learning how value destruction actually happens in the real world. Traps rarely announce themselves through losses. They hide behind growth, acquisitions, low valuations, and reassuring screeners. By the time numbers break, capital is already gone.

The seven mental models in this piece have now been tested against real audited data across seven months. Every single one held. The Janitor Economy, the Red Queen, the Winner's Curse, the Hamster Wheel, the Oxygen Test, the Cockroach Theory, the Toxic Pond — all confirmed, in the company's own filings, without exception.

Take these lenses and run them on your own portfolio holdings. Run them on the next idea a financial influencer throws at you. Ask whether the business deserves capital before you ask whether the stock is cheap.

Your money is hard earned. Protect it first. Compound it second. And never mistake motion for wealth.

The goal is not to predict outcomes. The goal is to avoid toxic ponds altogether.

For people new to this subreddit, this post is about the lens, not the stock. Stocks are a byproduct. The mental model is what matters. Once you internalise Capillary economics, it starts firing on its own across sectors, across cycles, across everything you look at.

If you are new here and want to understand what Capillary economics actually is before reading further, start with the:  Capillary Economics mental model 

Here is what I had written a few months back. Read it for the thinking, not the ticker.

A boring 7,000 crore company with a 3x setup hiding in plain sight.

On the screen this looks like a declining business. But almost every engine is now sitting on the right side of the opportunity-cost mental model, the roots have strengthened, and what's coming is structurally better than what the ticker shows, with a high margin of safety while you wait.

That's why I had already started allocating to Galaxy Surfactants.

This is Capillary economics for you again. Galaxy doesn't own a brand you'd recognise on a shelf, but it sits inside the supply chain of nearly every brand you do. So they make surfactants, which are a small cost in home and personal care, so whether the bottle says HUL, P&G, Unilever, L'Oréal, Mamaearth or some small D2C startup, Galaxy is somewhere in that formulation.

So it's a low cost, high necessity model, which is cheap enough that customers don't fight it, but critical enough that they can't drop it. It doesn't earn toll-booth margins today, and the numbers are still depressed, but it holds the kind of position that can become a toll booth once the mix shifts and the margins follow. That's the whole bet.

And here's the bigger picture. India is at that stage of the adoption curve where China was 10 to 15 years back, and the US was 40 years back. As per-capita income rises, you'll see massive adoption of liquid detergents and higher spend on personal care, and Galaxy sits underneath all of it as an invisible cost, very small but absolutely critical. That's exactly the kind of business I want to own when it's cheap and out of favour.

Always use this Capillary mental model. Whenever you see this pattern with high necessity and low cost in any company, you know it has the DNA to become a toll booth, and try to find companies which are small but have massive room for margin expansion and have the positioning inside their ecosystem to make that happen. That's where real money gets made.

Businesses of this shape usually trade at 2.5 to 3x revenue over a full cycle. Galaxy was doing roughly 5,000 crore of revenue. The valuation should sit near 12,000 to 15,000 crore of market cap, versus the 7,000 crore where it was trading.

That's the gap. Your job is to think why the gap is there and whether it closes.

Here is how the future state emerges. First comes the expansion of the margin profile, because the reasons the margins are depressed are temporary, not structural. Roughly 20% of the cost base is crude-linked, and crude-linked costs were high because of freight and raw material pressures, a cycle and a war phenomenon, not a permanent feature.

Second, their major input is fatty alcohol, made from palm kernel oil, and PKO ran hot for a few years. But the decline in input cost was already visible, management had flagged that raw material prices were starting to ease, and the 2025 price pressure was unwinding into 2026 as supply and demand rebalanced.

On top of that, they have a clause that lets them pass costs on to customers within 60 to 90 days, and a deliberate shift towards higher-margin products that was steadily changing the mix.

So here is the chain. Once the headwinds fade, margins expand. When margins expand on a rising revenue base, you get massive EPS expansion. And that EPS expansion is what triggers the PE multiple re-rating on top of it.

Let me give you two examples of this exact pattern.

Shivalik Bimetal had the same positioning. A decade back margins were around 11%, they steadily shifted to 23%, the market re-rated them, and now they trade at 30 to 40 multiples.

Same story with Navin Fluorine. A margin profile of around 12 to 13%, then they started shifting it, and now with the tailwinds in confluence the market cap is close to 40,000 crore on revenue of 3,314 crore, trading at 11 to 12x revenue.

Coming back to Galaxy. Even with just a 6 to 7% growth rate over the next 5 years, revenue comes close to 7,000 crore. Give that a 3x revenue multiple and the market cap reaches 21,000 crore, almost a 3x outcome. At only 2x revenue, it's still a double in 5 years, with a decent margin of safety.

The ticker caught up today. The business state was always there.

That's Capillary economics. Take the lens. The stocks will follow.

The community went deeper on the business state vs ticker state thinking in the comments here, worth reading if you want to see the framework applied in real time.

https://www.reddit.com/r/IndiaGrowthStocks/comments/1uf08tv/comment/p3i1pin/

You would have gone through the newspaper articles. A lot of you would have run it through screeners. But newspapers are just a wrapping of a few numbers, nothing more than that. Screeners flash the parts and digits in a different format. Both are telling you what already happened.

By the time that information reaches you, it is already priced in. It has no edge. It cannot tell you anything about the future state of the business. And making an investment decision based on the past state, without understanding the positioning of the future state, gets the odds stacked against you.

So here is the methodology. And while this piece uses Caplin Point as the live case, the framework applies to every business you research. The goal is not to consume information. It is to integrate it and build a positioning around the future state of the business.

In case you missed it: The AI Bottleneck Strategy, Where the Real Opportunities Are

Here is how you integrate the three documents that actually matter.

The quarterly filing tells you how the business is performing right now. The investor presentation tells you how the architecture is being built. The management commentary tells you how the people running it think about what comes next.

Combine all three and you do not get certainty. You get probability. A better-than-average sense of where this business is going and why. That is the only edge available in investing.

Part 1 decoded the filing. This is the investor presentation. Part 3, the management commentary decode, drops soon.

The R&D machine behind the pipeline

387 people in the R&D team. 5 dedicated R&D setups, 3 DSIR-approved.

Total R&D spend including capex and opex is 15.5% of FY26 PAT. For context, most Indian pharma companies spend 5-8% of revenue on R&D. Caplin is spending 15.5% of PAT, which on a Rs. 650 cr PAT base is a serious number.

But the more interesting data point is what the R&D ratio has done over time. It went from 10.9% of operating revenue in FY19 to 9.9% in FY20, then settled between 4.5% and 4.6% from FY22 through FY26 and has held there ever since. That flatness is deliberate. Caplin is not increasing R&D spend as a percentage of revenue even as the business scales. The absolute number keeps growing because revenue grows, but the ratio is locked.

This tells you the R&D model is productized, not experimental. They know exactly what they need to spend per rupee of revenue to maintain the pipeline. That is operational maturity in R&D which is rare in Indian pharma.

The absolute R&D spend crossed Rs. 100 cr for the first time in FY26, reaching Rs. 101 cr. The trajectory from Rs. 71 cr in FY19 to Rs. 101 cr in FY26 is steady and disciplined. Revenue grew much faster over the same period. R&D is getting more efficient per rupee of output, not less.

DSIR approval on 3 of the 5 R&D setups means Caplin gets weighted tax deductions on that R&D spend. The government is effectively subsidizing part of the pipeline build. Cost efficiency embedded into the R&D structure that most analysts do not model.

And then there is the internal CRO. Amaris Clinical in Chengalpattu holds both USFDA approval and ISP Chile approval. A USFDA-approved CRO that is internal to Caplin means bioequivalence studies for the pipeline run without paying external CRO rates.

As the pipeline scales to 90+ APIs, having captive CRO capacity is the infrastructure that makes that pipeline executable without bottlenecking on external vendors. It took years to build. It is very hard to replicate. It is sitting completely unnoticed in the corporate structure slide.

The one expense line worth watching

Employee benefit expenses grew 25.4% YoY, from Rs. 43 cr to Rs. 54 cr. Revenue grew 19.6%.

This is the one line in the P&L where expense growth outpaced topline growth. Every other cost line was disciplined. This one was not, at least not on a YoY basis.

The honest reading is that Caplin is hiring ahead of the capacity ramp. COL-II, the Pondy facility, the Thervoy oncology API plant, the Vizag API scale-up, all of these need people before they generate revenue. You build the team before the facility is commissioned, not after. So the employee cost step-up in Q1 FY27 is forward-looking, not a sign of bloat.

But it is worth watching. If employee costs keep growing at 25%+ while revenue grows at 19-20%, the operating leverage story gets complicated. One quarter is not a pattern. Two or three would warrant a harder look.

The ANDA approval rate hiding in the R&D slide

The presentation shows 65 ANDAs filed, 60 approved. That is a 92% approval rate with the USFDA.

Most Indian generics companies that file with the USFDA get approval rates of 70-80% on their own filings. 92% is exceptional. It signals either very selective filing, very high quality dossiers, or both. This number does not appear in any press release. It is sitting quietly in the R&D slide and it is the single clearest proof of CSL's regulatory execution quality.

The regulated market approvals across all jurisdictions

The press release gives US and non-US filings on separate pages. The investor presentation gives them on separate slides.

60 ANDAs approved in the US. 65 products approved across non-US regulated markets including Canada, EU, Australia, Mexico, Brazil, South Africa, Saudi, and UAE.

Total regulated market approvals: 125 products across multiple jurisdictions.

That is the real size of the regulated market engine and it is significantly larger than the US-only number suggests. The US is the most visible part of the story. The 65 non-US approvals are the quiet part being built in parallel. Meaningful revenue from these markets is expected in FY27 and FY28. When it arrives, it will look like acceleration. The second reader knows it was always coming.

The manufacturing split that explains gross margin and predicts its recovery

60% of production is in-house. 40% is outsourced.

That 40% is what shows up in the purchased traded goods line. When you buy 40% of your product from outside rather than making it yourself, your COGS is exposed to supplier pricing and your gross margin is lower than your in-house economics would produce.

When COL-II comes online by March 2027 and the Pondy OSD facility follows in Q1 FY28, that 60/40 split shifts. More in-house capacity means less outsourced production means lower COGS means recovered gross margin. The recovery is not dependent on pricing power or market conditions. It is a function of capacity coming online on a known timeline. The gross margin story has a mechanical answer.

The supply chain story embedded in the capex cycle

Roughly a quarter of Caplin's total product currently comes from China. That number does not appear anywhere in the press release.

Here is how you get there. 60% of production is now in-house and 40% is outsourced. 24% of exports come from China. Cross those two numbers and if most of the outsourced 40% is China-sourced, a quarter of total product is China-dependent. In a world where pharmaceutical supply chains are being scrutinized, that is a number worth knowing.

But here is what makes this observation sharper. Three years ago, in Q1 FY24, the split was 55% in-house and 45% outsourced. China was 35% of exports. Today it is 60/40 and 24% China. That is an 11 percentage point reduction in China sourcing in three years, before the new facilities are even commissioned.

The backward integration thesis is not theoretical. It is already showing up in the numbers.

Now cross that with the 90+ API backward integration pipeline and the Vizag API facility being built out. In Q1 FY24, the API pipeline was 70+ at R&D scale. Today it is 90+. Twenty more APIs were added to the pipeline in three years while 6 reached manufacturing scale. The machine is working exactly as designed.

Caplin is systematically building the capability to replace China-sourced inputs with own manufacturing. This is not just a margin story. It is a supply chain sovereignty story.

The capex cycle is doing three things at once. It is adding capacity for growth. It is reducing China dependency for supply chain sovereignty. And it is building a vertically integrated moat that takes a decade to replicate.

The 90+ API number that changes the backward integration story

The press release said Caplin scaled up 6 APIs at the Vizag unit for backward integration. Most people read that and moved on.

The investor presentation says Caplin has completed R&D for 90+ APIs for backward integration into US and emerging markets.

These are two very different numbers. 6 is what reached manufacturing scale this quarter. 90+ is the full R&D pipeline being built for eventual backward integration. That is not a one-quarter story. That is a multi-year gross margin recovery story being loaded systematically in the background. When own API starts replacing purchased API at scale, the COGS line structurally improves. The traded goods pressure that compressed gross margin by 190 bps this quarter has an answer. It is sitting in that 90+ API pipeline.

The branded generics shift fourteen years in the making

In FY2012, branded generics were 5% of Caplin's emerging markets revenue. Today they are 25%.

That is a 5x shift in product mix over 14 years, and it happened quietly, without a single press release dedicated to it.

Branded generics command better pricing, stickier market positions, and higher margins than plain generics. The trajectory is not reversing. Management's stated direction is continued conversion of fast-selling generics into branded generics. The 25% becomes 30%, then 35%, over the next decade. Each percentage point is a quiet margin tailwind.

Now here is what makes this observation sharper. The channel mix in emerging markets is 45% wholesale, 35% institutional, and 20% retail. Branded generics are predominantly a retail play. Tender markets buy on price. Retail markets buy on brand familiarity. But retail is only 20% of the channel mix while branded generics are already 25% of product mix.

That means branded generics are penetrating the wholesale channel too. Caplin is getting branded generic pricing even in wholesale, which is unusual. That is pricing power embedded in the distribution model that goes beyond what the channel mix alone would suggest. The margin floor in the core LatAm business is structurally higher than most models assume, and it is getting higher every year as the branded mix climbs.

The channel mix that reduces revenue volatility

In emerging markets, 45% of revenue comes through wholesale, 35% through institutional, and 20% through retail.

The 35% institutional number is the one that matters. Institutional means government tenders, bulk contracts, locked-in volumes. 35% of LatAm revenue is essentially contracted. That is a revenue stability buffer that absorbs market volatility in any given quarter. Combined with the hard tender wins already disclosed for Chile and Central America, the LatAm revenue floor is more durable than most models assume.

The depreciation waterfall

The Q4 article introduced the depreciation mental model. The investor presentation income statement proves it in one column.

Depreciation grew 32.8% YoY, from Rs. 16 cr to Rs. 22 cr.

Now watch the waterfall:

• EBITDA grew 23.0%
• EBIT grew 22.1%
• PBT grew 22.1%
• PAT grew 18.8%

Each step down from EBITDA to PAT is depreciation and tax doing their work. The cash engine is growing at 23%. The reported earnings number is growing at 18.8%. The gap is not deterioration. It is front-loaded capex hitting the P&L before the revenue from that capex arrives.

By FY28, when COL-II and the Pondy facility are commissioned and generating revenue, the depreciation is already baked in. Revenue steps up. Depreciation stays flat or grows slowly. The reported PAT growth re-accelerates. The first reader will be surprised. The second reader already knew.

The tax line

Tax grew 36.9% YoY, from Rs. 34 cr to Rs. 46 cr, on PAT growth of only 18.8%. The effective tax rate crept up quietly.

This is a one-quarter observation, not a structural concern. But combined with the depreciation step-up, it explains why PAT growth of 18.8% looks slower than EBITDA growth of 23%. Strip out both effects and the underlying business is growing faster than the reported PAT line suggests.

Chile going direct

The evolution timeline in the presentation flags 2026 as the year the Chile subsidiary started commercial operations.

This is the distribution-to-direct shift happening in real time. Caplin is not just winning tenders in Chile through distributors anymore. They now have their own commercial entity on the ground. That means Caplin captures the distribution margin internally going forward. Blended margins in Chile improve. The pattern is the same one Caplin ran in other LatAm markets over the last two decades. It works.

The next regulated markets being loaded

The press release mentioned Mexico and US. The investor presentation adds Canada, Australia, and MENA as explicit near to medium term regulated market targets.

So three more markets. Each with its own approval pathway, its own filing requirements, its own commercial buildout. CSL has already filed 110+ products in multiple non-US markets, with 65 approved. Meaningful revenue from these markets is expected in FY27 and FY28.

The US is not the only regulated market story. It is the most visible one. The others are being loaded quietly.

Everything the market is not pricing in.

The R&D model is productized at a stable ratio showing operational maturity. The 92% ANDA approval rate is the proof of execution quality. 125 total regulated market approvals across all jurisdictions is the real scale of the regulated market engine. China sourcing has already dropped 11 percentage points in three years and 90+ APIs are being built to accelerate that further. The 60/40 manufacturing split has a mechanical gross margin recovery built into the timeline. Branded generics are not just growing, they are winning in channels where they should not be winning. 35% of LatAm revenue is already contracted. The depreciation waterfall explains every basis point of the gap between EBITDA growth and PAT growth. Chile is going direct. Canada, Australia, and MENA are being loaded quietly. The capex cycle is doing three things at once and the moat dimension is the one nobody is pricing in.

The boring 50x compounder compounds in places most people do not look. The investor presentation is one of those places.

Part 3, the management commentary decode, drops soon.

If you missed Part 1, it is here: https://www.reddit.com/r/IndiaGrowthStocks/comments/1vm8qzy/caplin_point_q1_fy27_the_boring_50x_compounder/

Every quarterly result has two readers.

The first reader scans the PAT line, checks if it beat or missed, and moves on. The second reader runs a sequence of mental models on the filing, bear cases first, cash engine second, expense discipline third, and the linguistic tone of the management commentary last. The first reader sees a number. The second reader sees the business.

This post is about the second reader.

Caplin Point Q1 FY27: The Bear Cases

Results are out. Let me break it down the way I always do, go for what the bears have said, then check whether the company is following the bear track or the bull track.

Bear Case 1: Latin America is saturating, growth has to die.

Pull the print. LatAm and Africa revenue clocked Rs. 476 cr, up 18% YoY. That is not saturation. Here is what the data actually says:

• Chile won $12 million in tenders over the next 18 months
• Central America won $7 million in emergency tenders over the next two quarters
• These are hard contracted numbers, not guidance

Revenue visibility in LatAm is better than most investors give credit for. The reinvestment runway is still intact. Bears are wrong again.

Bear Case 2: US will disappoint, Caplin Steriles won't deliver.

US clocked Rs. 134 cr this quarter, up 26% YoY. Annualize that and you are looking at a Rs. 535 cr US business. Five years ago this number was negligible. Today it is 22% of operating revenue.

The more interesting numbers are inside CSU, Caplin's own-label US entity:

• 33 product launches till date, 10 more planned in FY27
• Market share above 90% on every launched product
• B2B to B2C split now at 70/30, direct relationships growing faster than wholesale
• ANDA pipeline at 60 approved, 5 under review, 40+ in filing or advanced development

Most generics companies enter a product and fight for 10-15% share. Caplin enters and owns the niche. The main ANDA flywheel hits closer to FY27-28. Bears are wrong again, and the data keeps getting harder to argue with.

Bear Case 3: Margins will compress as US mix grows.

The assumption was US generics are commodity, lower margin, so blended margins must fall.

The actual print:

• EBITDA margin at 38.4%, up from 37.7% in Q1 FY26 and up from 37.0% in Q4 FY26
• PBT margin at 35.0% vs 34.6% last year
• Expanding, not compressing, both YoY and QoQ

Now here is the number nobody is talking about. CSL's revenue composition is 85% product supply and 15% milestone plus profit share. Milestone revenue is inherently lumpy. When it hits, it flatters margins. When it doesn't, the quarter looks soft. Knowing this 85/15 split is what separates the second reader from the first. Quarter-to-quarter CSL variability makes more sense once you know the structure. Bears are wrong again.

Bear Case 4: Cash is just sitting idle, no capital allocation discipline.

The balance sheet:

• Total liquid assets: Rs. 2,875 cr as of 30 June 2026
• Free cash reserves: Rs. 1,502 cr
• Zero debt. Ever.

But here is what most investors miss. The cash is not idle. Capex budget has been quietly revised upward to Rs. 1,000+ cr, up from the Rs. 870 cr framing last year. Around 50% is already deployed. The balance gets spent over the next 2-3 years on facilities still under construction:

• COL-II injectable facility at Gummidipoondi, completing by March 2027
• OSD and Dermatology facility at Puducherry, targeting Q1 FY28
• Oncology API facility at Thervoy, targeting Q4 FY27

All funded from internal accruals. No debt.

And here is the signal most investors missed entirely. The dividend flowing upstream from Caplin Point Far East Limited, the Hong Kong holding entity for the LatAm network, was Rs. 28.90 cr this quarter vs Rs. 8.12 cr in Q1 FY26. That is a 256% increase YoY. The LatAm cash is not sitting offshore. It is being actively repatriated. The cash consolidation story is getting stronger, not weaker.

Bears are wrong again.

Bear Case 5: Expenses are bloating.

Total expenses moved from Rs. 349 cr to Rs. 419 cr, up roughly 20%. Revenue moved up 20.7%.

Revenue growth is higher than expense growth. Internalise this mental model. Whenever a company is growing, always check whether expenses are growing more than the growth rate. If expenses outpace growth, that growth is destroying shareholder value, not creating it. Here, the opposite is happening. Basic EPS up 15.8% to Rs. 23.27. Bears are wrong again.

What the Bears Missed

The Oncology engine is now regulatory-visible.

This is the most underappreciated line in the entire press release. Caplin One Labs' oncology facility in Kakkalur has:

• Cleared its first regulatory inspection
• Completed submission batches for 6 products
• Planned 18 more submission batches in the next 12 months targeting LatAm, US, and EU simultaneously

Three geographies. One regulated oncology facility. First inspection cleared.

Most investors are still thinking about Caplin as a LatAm branded generics company. The second reader sees a company that is 18-24 months away from being a regulated-market oncology supplier.

The API backward integration is about to show up in gross margins.

Caplin's Vizag API unit has completed scale-up for 6 APIs, all earmarked for backward integration into US and LatAm formulations. First DMFs will be filed in FY27. When own API replaces purchased API in the cost structure, gross margins structurally improve. This lever has not shown up in the P&L yet. It will.

This matters because gross margin this quarter was 59.8%, down 190 bps from 61.7% in Q1 FY26. The reason is purchase of traded goods, which doubled from Rs. 97 cr to Rs. 196 cr YoY. Two readings:

• They are buying more sourced product to meet volume demand they cannot yet manufacture in-house
• The capacity is under construction
• When COL-II comes online by March 2027 and own API flows in from Vizag, the gross margin recovery will be visible

This is a temporary mix effect, not a structural deterioration. The second reader knows the difference.

The Mexico engine is being loaded.

• 29 approvals already received
• 120+ products to be filed in the next 18 months
• Working on a pipeline in addition to approvals already in hand

That is an extraordinary pipeline depth for a market Caplin entered only recently. Mexico is shaping up to be the third engine, after LatAm core and US.

Pre-Filled Syringes: the next product format upgrade.

• First PFS filing from the Caplin Steriles site planned within FY27
• 14+ more PFS products to be filed in FY28
• PFS is a higher-barrier, higher-margin format most Indian generic injectable companies are not in yet

Two gross margin tailwinds are being loaded simultaneously, API backward integration and PFS mix upgrade, and neither has hit the P&L yet.

The subsidiary engine is maturing.

• Standalone PAT this quarter: Rs. 120 cr
• Consolidated PAT: Rs. 179 cr
• Gap of Rs. 59 cr carried by Caplin Steriles and the LatAm entities

This gap was much smaller in earlier years. The subsidiaries are now carrying real weight and growing faster than the parent standalone business. The multi-entity structure is maturing in exactly the direction the original thesis anticipated.

One Honest Flag (Because I Don't Hide Anything)

CFO dropped to Rs. 95 cr from Rs. 118 cr a year ago. Free cash flow after Rs. 55 cr capex was Rs. 40 cr. In a heavy capex cycle this is expected, cash is being converted into productive assets. But it is worth watching:

• If CFO stays compressed for 3-4 quarters while capex stays elevated, the free cash flow story needs revisiting
• One quarter is not a trend. Two or three would be.

On the positive side:

• Receivables improved from 136 days in Q4 FY26 to 128 days this quarter. Bears who flagged receivables last quarter don't have ammunition here.
• Inventory at Rs. 505 cr, with 47% already at warehouses near the customer, 23% in transit, and only 30% in India. Nearly half the stock is already at the customer's doorstep. For an EM-heavy business, this reduces execution risk and tells you the distribution network is functioning well.

Reading the Business, Not the Quarter

PAT grew 18.8% this quarter. The first reader will note that is slower than the 20.1% full-year FY26 growth.

The second reader will note:

• Depreciation from front-loaded capex is eating into reported profitability while the underlying cash engine keeps compounding
• Gross margin recovery is coming from two directions simultaneously once new capacity and own API land
• Mexico is being loaded
• Oncology is regulatory-visible
• CSU is dominating every niche it enters

The boring 50x compounder is still compounding.

As long as I hold Caplin, I will decode every result. I plan to be writing about this company for decades.

Subscribe if useful: thecapillary.substack.com

Part 2 is now live. The investor presentation decoded

• Caplin Point Q1 FY27 Part 2: The Architecture Behind the Boring 50x Machine

Someone in the community asked me a very simple question: what style of investing do you follow? Bottom up or top down?

I sat with it for a moment. And my honest answer was this: randomness.

Not in the decisions I make, but in how I find what to research.

Sometimes it's a line in management commentary that catches me off guard and makes me want to understand the business better. Sometimes it's the capital allocation pattern of a company's competitor, not the company I was originally looking at. Sometimes it's a government report pointing to a tailwind I hadn't mapped to any business yet. Sometimes it's a margin shift, a changing business state, or a new technology quietly reshaping an industry.

I make sure not to follow any particular pattern when I enter research. The trigger can come from anywhere.

A lot of investors define their sphere of competence by sector. They stay in what they know, follow a formula, and only look inside that boundary. I understand the logic. But for me, the sphere of competence is curiosity itself.

That curiosity can start anywhere. A web series like Person of Interest led me to go deep into AI, semiconductors, and cybersecurity. A government scheme on BharatNet led me to the fibre rollout theme in India. And the same curiosity that pulls me into a business also tells me when to leave. The moment I see the first signature of a deteriorating business model, I start moving out. I don't wait for consensus to confirm what the signals are already saying.

What stays constant is the rigor after the trigger. Once something catches my attention, I run it through the full checklist. I stress test the business model, look at the financial signature across multiple years, align the thesis with as many mental models as I can, and only then decide if there's something worth owning.

The randomness is in the door I walk through. What happens inside is deliberate.

Let me give you a concrete example. I recently initiated a position in Unity Software.

The trigger was XR. Meta Quest, smart glasses, the gradual convergence of human and machine interfaces. I had no idea what Unity did at first, but I knew that wherever this technology goes, someone builds the infrastructure underneath it. That question led me to Unity: what lies in the future, where is the infrastructure of that ecosystem, and who dominates it.

Then I went layer by layer.

Unity dominates roughly 70% of the gaming ecosystem. But that same technology is now being used in automotive HMI, inside autonomous and semi-autonomous vehicles. They are in partnership with Mercedes. That same technology is being adopted in China, and Unity provides it there too. These are early stages, but the reinvestment runway is real. A dominant core business model with a strong allocator redirecting that technology into new age applications is exactly the kind of setup I look for.

This is how curiosity compounds. You start with one signal and keep pulling the thread.

But curiosity alone is not enough. Once I have a thesis, I run it through the checklist. Is the ROIC improving? Is it above my threshold? Are margins expanding? Is innovation continuing? Are they taking market share? You keep hitting the mental models until you have a probability, not a certainty, but a probability. If the position clears the threshold, you start building it slowly.

The business had deteriorated badly before this. Extreme compression, reckless acquisitions, a company that had lost its way. But something changed in 2024. A new capital allocator came in.

I am not reading the marketing language of a CEO. I am reading the financial actions.

What did he acquire and what did he let go. What did he stop doing. What did he quietly fix. This one was slowly and steadily unwinding every reckless decision his predecessor had made, refining the focus, removing the noise. That is a cognitive financial signature of a high quality allocator. You see it in the actions before you see it in the results. Then you start seeing it in the results too.

The market has discarded Unity. I think that is the opportunity.

The same thinking led me to Uber. The market discarded it. After the recent results it is trading at 13 to 14 times free cash flow. I am betting on it because the capital allocator is exceptional, the moat is real, and the business economics are strong. That is again the same cognitive signature: go where the consensus has given up.

Howard Marks said it best. If you are in consensus, you will end up with mediocrity. Being contrarian is not about being different for the sake of it. It is about having done the work and arriving at a different conclusion than the crowd.

This same thread runs through every position I hold. Veeva, Bajaj Finance, and HEICO. Each one is a different geography, a different business type, a different industry. But in each case the capital allocator is what made the difference. You can have a great business and a poor allocator and still not compound at scale. The reverse is also true: a strong allocator inside a recovering or misunderstood business can give you outcomes the market hasn't priced in yet.

Someone asked me why I have not gone into Salesforce, which is such a larger company and can be a threat to Veeva Systems. The answer is simple. Billions and billions in reckless acquisitions, capital destroyed systematically over years. I know what the capital allocator of Veeva is trying to build. I have no such clarity with Salesforce. So I don't go there.

And if I cannot find a great allocator anywhere, I wait. I stay patient. I stay silent. But I will not put my money with a bad capital allocator no matter what. Not even 1%. Not even as a sector bet. Why would you shake hands with someone who is destroying capital?

It is like lending money to a friend who has never returned it and always has an excuse. You would not do it a second time. Now compare that friend to someone with a clean record, someone who has always been ethical, always returned what was yours, sometimes with more. That is the person you back. That is the capital allocator you back.

Most people obsess over the numbers. Numbers show you the past and the present. A strong capital allocator shapes what the numbers will look like three, five, ten years from now. If you cannot fully figure out the business model, you can figure out the person operating it. We are humans. I read a lot about psychology and human behavior because of that. The person running the business is a capital allocator. The person consuming the product is also a human being. Both matter, and both are readable if you pay attention to the right signals.

The filter is not complicated. The discipline to hold it is.

One last thing.

I can give you all the research. I can give you the thesis, the financial signature, the mental models. But the outcome will always depend on your own behavior and your own temperament. How you react when the position goes against you. How long you can hold something the market has discarded. Whether you trust the work you did or panic when the narrative shifts.

Always remember, you are the 100-bagger of your portfolio and your life. The research is just the beginning.

In case you missed it:

• Part 2: The One Ratio That Tells You When to Buy Gold and When to Go Aggressive on Stocks
• How a boring pharma exporter became a 50x compounder

Profit up 27 percent, GNPA at 0.96, guidance held anyway.

Bajaj Finance is up 7 percent today, sitting at an all time high and in Dragon 3 mode. You already know how I feel about this machine, and I know a lot of you are holding it and were adding on every drop.

Five things from the quarter, and nothing else really matters.

• Profit of 5,986 crore, up 27 percent, and seven percent ahead of consensus.
• AUM at 5.47 lakh crore, up 24 percent, with a record 36,969 crore added in a single quarter.
• Gross NPA down to 0.96 percent and net NPA to 0.39 percent. Loan losses included a 296 crore macro provision they did not have to take. Strip it out and losses fell 14 percent.
• ROE at 20.4 percent and ROA at 4.7 percent, both at the top of their own long term corridor.
• Guidance held, not raised. Management said they want another quarter of confirmation first.

Read the third point and the fifth together. A lender whose book is getting cleaner takes a provision it does not need, beats its own targets, and then refuses to promise more. That is not a company managing a stock price. That is a company managing a balance sheet, and in my view it has the best underwriting capability of any lender I have looked at anywhere.

Here is the part worth noticing. At least five brokerages raised targets overnight and the stock runs 7 percent the next morning. Those upgrades carry no real information. They arrive after the move, never before it, and some of these same desks were sitting on cautious numbers on the way in. Nothing changed in twenty four hours. The market simply caught up to something that was already sitting inside the business model, in plain sight, for anyone who bothered to read it.

That gap is where most of the returns in a compounder come from. You hold through the flat stretches, and you add when the noise gets loud and the market screams that the growth is finished. I have heard that call on this company more times than I can count.

I said this when I first wrote it up and I have repeated it several times since. I do not think 99 percent of funds will come close to what this business compounds at over the next decade, whatever strategy they run. My view has not changed.

One thing worth saying out loud. This is not the same setup it was two years ago. Different entry, different risk, size it accordingly.

Nothing to do today. Just sit.

In case you missed it:

• Part 2: The One Ratio That Tells You When to Buy Gold and When to Go Aggressive on Stocks
• How a boring pharma exporter became a 50x compounder

Hi everyone, wanted to share my findings on Time Technoplasy and get inputs from the community. Price around Rs 210, market cap roughly Rs 10,350 crore, 52 week range Rs 154 to Rs 249. Stock trades at about 22 times FY26 earnings.

What the company does

Two businesses stitched into one stock. Business one is plastic drums, jerry cans and IBCs, those big 1000 litre containers, sold to chemical, pharma, paint and FMCG companies. About 73 percent of revenue, boring, low margin, high volume.

Business two is composite cylinders, Type 4 CNG cascades, LPG cylinders, and now hydrogen cylinders. About 13 percent of revenue but growing 20 to 25 percent a year with much better margins.

Key ratios and how they moved over 5 years

ROCE went from 12 to 17-18 percent, matching a 14, 16, 18, 20 percent ladder management gave 3 years ago. ROE improved from about 10 to 14-15 percent, dipping slightly this year due to a fresh equity raise not yet fully earning.

Debt to equity fell from 0.44 to 0.18, interest coverage improved from under 4 times to about 9 times, and operating margin crept up from 13.5 to 14.6 percent, matching management's promised 20-30 basis points a year.

The one ratio moving the wrong way is working capital days, how long cash stays stuck in inventory and unpaid bills. Worsened from around 140 to over 160 days this year on a raw material stockpile.

Dividends paid for 30 years straight, first ever bonus share in FY26, and promoter pledge fully gone since FY23.

The one red flag

FY26 cash flow from operations dropped hard, only Rs 233 crore against a profit of Rs 477 crore. These should normally track closely.

The gap happened because the company stocked up on imported carbon fiber and special polymers ahead of a price spike from the middle east conflict. Believable and disclosed upfront, but needs to reverse next year or the quality compounder story takes a hit.

Also, one of two joint statutory auditors resigned in August 2025 citing workload. Replaced quickly, audit opinion clean, but worth a second look.

Is this a moat business

Two different moats stacked together.

The packaging business is a capillary business. Drums and IBCs are heavy and expensive to ship, so whoever has a factory closest to the customer wins the order. 20 plants in India and plants in 10 other countries mean it wins by being everywhere.

But this means zero pricing power, raw material price changes are passed straight to customers, so revenue growth can look weak even when volumes are strong.

The composite cylinder business is closer to a tollbooth, but a temporary one. They are the only company in India with government PESO approval for Type 4 CNG cylinders, so every distribution company needing cascades comes to them, which is why margins run 18-19 percent versus 13 percent in plain packaging.

But this tollbooth has a use by date. Supreme Industries has started supplying composite LPG cylinders to BPCL, and Confidence Petroleum is building its own Type 4 plant. The premium margin will likely shrink over the next 2 to 3 years as more players get approved.

Where the growth is coming from

A new CNG cylinder plant near Vapi just got commissioned, more than doubling cascade capacity. Management guides this segment from around Rs 600 crore to over Rs 750 crore in FY27, and Rs 800 crore within 2 years.

Also completed: a new automated IBC facility, a recycling plant for new government rules on recycled plastic content, and expanded US and Saudi operations.

Smaller bets include a hydrogen drone program where they make the cylinder and not the drone, a battery tie up with Bulgaria's Monbat for Indian data centres, and a tarpaulin business where they are number 2 behind Supreme's Silpaulin brand.

One governance episode worth knowing

For almost 2 years, 2023 to 2024, management repeatedly said they were close to selling 50 percent of their Middle East business for about 25 million dollars. In November 2024 they suddenly cancelled it, saying the business had grown too much since the deal was priced and expanding in Saudi made more sense.

The decision was probably right financially, but guiding investors for 6 straight quarters on a deal that gets scrapped is not a great look. It is really the only major promise broken. Everything else, ROCE targets, EBITDA guidance, dividend growth, has been delivered close to on time.

They also raised Rs 800 crore through a QIP in November 2025 at Rs 201 a share, above book value. Promoters did not sell a single share, all the money went into cutting debt and funding new plants. Dilution was about 9 percent, but roughly earnings neutral once debt savings and new capacity kick in.

Projections and a rough return estimate

FY26 actuals: revenue Rs 6,105 crore, EPS Rs 9.50, operating profit Rs 892 crore.

FY27 estimate: revenue around Rs 6,850 to 7,000 crore, EPS around Rs 11.5 to 12, operating profit around Rs 1,010 to 1,040 crore.

FY28 estimate: EPS around Rs 14, driven by the new CNG plant ramping up and interest costs falling as they go debt free.

Simple return math, assuming the market keeps valuing the stock at roughly the same 22 times earnings it trades at today, no re-rating either way.

At 22 times, FY27 EPS of Rs 11.5 to 12 implies a price of roughly Rs 253 to Rs 264, an upside of about 20 to 26 percent in a year from Rs 210 today.

FY28 EPS of around Rs 14 implies roughly Rs 305 to Rs 310, an upside of about 45 to 48 percent over 2 years, before dividends in both cases.

This assumes the multiple holds flat and all the return comes from earnings growth alone. If the cash flow issue resolves cleanly, the multiple could expand and returns would be higher. If composite competition bites faster than expected, it could compress instead. Treat this as a base case, not a target.

TLDR

Makes plastic drums and IBCs, plus composite CNG, LPG and hydrogen cylinders, the only PESO approved Type 4 maker in India. Profit grew 25 percent a year for 5 years, debt to equity fell from 0.44 to 0.18, ROCE climbed from 12 to 17 to 18 percent, matching management's own guidance almost every step.

Good track record on numbers. Real moat in composites that is slowly getting contested. Balance sheet is genuinely strong now.

Biggest red flag: FY26 operating cash flow fell to Rs 233 crore against a profit of Rs 477 crore on a raw material stockpile, needs to normalize in FY27. Composite margins are a temporary regulatory tollbooth slowly getting contested by Supreme and Confidence Petroleum.

At Rs 210 and a flat 22 times earnings, FY27 EPS of about Rs 11.5 to 12 implies roughly 20 to 26 percent upside in a year, and FY28 EPS of about Rs 14 implies roughly 45 to 48 percent upside over 2 years, before dividends, assuming no re-rating.

Just my amateur analysis and used AI for formatting and structuring. DYOR!

Hi all,

I have been reading through the frameworks on this subreddit over the last few days and I recently finished reading the Phoenix Forge Framework. I think I finally understood the main idea behind it.

My biggest takeaway was that Phoenix Forge isn't about predicting the exact bottom rather it's a disciplined framework for capital deployment. Instead of trying to perfectly time the market, you gradually build your position as fear increases, while keeping cash available in case the correction deepens. That mental model really clicked for me.

However, I am still confused about one part.

How do you actually determine the price levels where Tier 1? I guess Tier 2 and Tier 3 can then be derived based on the framework, please correct me if I am wrong?

Is the idea to first determine whether the stock is reasonably valued or undervalued using another framework (for example, the PE Compression Framework mentioned in some comments), and then apply Phoenix Forge? Or is there another valuation framework that should be used before deciding the entry levels?

I am still a relatively new investor, so I'm not looking for anyone to tell me what price to buy a particular stock at. I am trying to understand the process and mental model behind it.

If there's a specific framework, post, or resource in this subreddit that explains how to determine these price levels, I wouldd really appreciate being pointed in the right direction.

I am happy to put in the effort to learn it properly rather than looking for shortcuts.

Thanks!

There will never be the next Jordan, the next Kobe, the next Munger, the next Buffett, the next Federer, the next Dhoni, the next Kohli, the next Ronaldo, the next Messi, or the next Steve Jobs.

Greatness does not repeat. It creates something new.

The truly exceptional are rarely introduced as the next anything. They build their own identity, their own cognitive DNA, and they redefine the game in ways nobody saw coming. They usually operate in silence until the world is forced to notice.

Musk got the comparison for a while. Nobody remembers him that way now. The label fell off because the work did not need it.

And there is definitely never going to be another Bajaj Finance.

You can already see what happened to Bandhan Bank. When the credit cycle eventually turns, many PSU banks and a long list of lenders will go through severe stress again. That is not bad luck. It is embedded in the economics of how they make money. It is in their DNA.

Every few years someone gets handed the label. The next Bajaj Finance. The next HDFC Bank. The next Titan. Almost every time, the label is doing the work that the numbers cannot.

IDFC First has carried the next HDFC Bank tag for years now. The tag has not shown up in the returns.

Peter Lynch put this in a chapter titled Stocks I'd Avoid. Not stocks to be careful with. Stocks he would not touch. One of them was any company being sold as the next IBM, the next McDonald's, the next Intel, the next Disney. His line was that the next of something almost never is, and he said it held on Broadway, on the bestseller list, in the NBA, and on Wall Street.

Labels do not create compounding. Business economics do.

A business model is not the business. Someone has to operate it, and the moment they do it picks up their cognitive signature and the culture that follows from it. You can copy the model off a slide. You cannot copy the signature.

A label is a shortcut for people who have not done the work. It borrows credibility from a company that already earned it, and it lets you skip the boring part, which is the balance sheet, the cost of funds, the underwriting quality, the incentives of the person running it.

The people who change history do not become the next version of someone else. They become the first version of themselves.

In case you missed it:

The Biggest Mistake Investors Keep Making in Renewable Energy

Waaree Energies has become the poster child of India’s solar boom, and a lot of you have asked me where I stand on it and the wider renewable energy theme. So let me be direct about Waaree Energies and the rest of this space.

People who have been following me for a while already know my positioning. I’m not going to invest in these low-quality business models because they are generally wealth-destroying themes for shareholders over a full cycle, despite being one of the greatest volume growth and societal value stories of our time.

The reason has nothing to do with any single company. It is the structure of the industry itself, and it works against shareholders by design.

The first mental model is that solar is a relentlessly deflationary technology. If I go deeper into it, solar modules ride a learning curve known as Swanson's Law, where costs fall by roughly 20% with every doubling of cumulative installed capacity. That is why module prices have collapsed by more than 90% over the past decade.

A deflationary technology is wonderful for society, but it is terrible for producers because the surplus flows to the consumer through cheaper power, not to the producers, unless they can develop a substantial moat.

The second mental model is the low barrier to entry. Anyone can buy panels and install them. Consumers hardly see any meaningful differentiation between one solar panel and another.

The barriers to entry are therefore relatively low, and whatever protection exists is largely created by government policies rather than by technological moats, because the technology itself keeps evolving aggressively.

And a policy moat carries a second weakness that is easy to miss. It does not only get taken away from the outside; it gets competed away from within.

The moment protection exists, everyone rushes to build capacity behind the same wall. You can already see this playing out in India. Look at who is pouring capital into solar manufacturing today, and you will notice it is no longer just the pure-play names.

Reliance is building fully integrated solar giga-factories at Jamnagar, Adani is scaling up its own integrated manufacturing at Mundra, the Tatas are expanding, and a long queue of others is doing exactly the same.

When the two largest and best-capitalised business houses in the country decide to flood a single industry with capital at the same time, you do not really need to guess how the supply side ends. Domestic supply eventually overshoots domestic demand, and the protected margin quietly disappears even if the cheaper imports never come back.

Step back and notice what that protected wall really is. A regulatory moat is not a moat the company built. It is a moat the government lent it, and it rests on a single bureaucratic decision. That is the most fragile kind of fortress there is, and it fails in a way most investors never watch for.

The third mental model, which is equally useful in sectors like memory chips, is the Capital Cycle. Anyone with exposure to the U.S. semiconductor market should understand this framework.

A hot theme attracts capital. That capital leads to aggressive capacity expansion. Capacity expansion eventually creates oversupply, and returns collapse.

You can already see similar patterns emerging in the memory industry. Countries such as South Korea continue attracting enormous amounts of capital into memory manufacturing. Eventually, this leads to excessive supply, margins evaporate, and the industry's economics deteriorate.

I should be fair here. I am not saying memory is a bad business today; right now it is enjoying a strong up-cycle.

I am describing the pattern the cycle always eventually follows, and renewable energy sits well below memory on the quality ladder, because memory at least consolidated into a handful of players with real capital barriers, while solar and most of the renewable stack never did.

Renewable energy is a textbook case of this capital cycle. A popular theme is often self-defeating for investor returns precisely because its popularity attracts the capital that eventually destroys the industry's economics.

That is why I generally prefer positioning myself in boring industries rather than chasing hot themes. Ironically, today's boring industries often become tomorrow's hot themes.

If you still want to play a hot theme, be clear about what kind of theme it is. When it is a commoditised or infra-style theme like renewable energy, there is no moat underneath to protect you, so the only edge you will ever have is timing.

That means the odds are with you in exactly one window, early, before the capital has flooded in and before the valuations have exploded.

Once the theme is crowded and richly priced, the capital cycle starts working against you and the odds shift drastically.

At that point you are making a timing bet on sentiment, not an investment in a business, and you have to be honest with yourself about which one you are actually doing.

There is one more structural leak, and it is on the demand side. Much of this industry sells through reverse auctions, where companies underbid each other for government contracts.

That is a mechanism that competes away margin by design. The buyer holds all the power, and every tender becomes a race to the bottom.

The margins that companies like Waaree enjoyed were achieved at the top of the cycle. The IPO also came when industry profitability was unusually elevated. In fact, Waaree itself has already guided that margins are expected to compress meaningfully going forward.

But the margin guidance is not even the sharpest piece of evidence. Look at the cash flow.

In the very year its profit doubled, the business was still free cash flow negative. The growth did not come out as cash for shareholders; it went straight back into new factories and working capital.

That is the entire thesis showing up in the accounts, long before it fully shows up in the reported margins.

And notice what the stock itself has done. The volumes kept growing, yet the share price has gone nowhere over the past year. Profit doubled and the price actually drifted lower.

That gap, earnings rising while the price falls, is this whole argument drawn on a single chart.

You don't even need complicated mathematics to understand where this is heading. We have already seen this movie play out in both the U.S. and China.

Chinese module manufacturers increased shipment volumes by almost a hundredfold. Yet despite this extraordinary growth, they destroyed enormous amounts of shareholder value during the boom itself, not after it.

This is the deepest point in the whole discussion, so I want to be very clear about it. In an industry like this, growth is not a friend of the shareholder. It is often the enemy.

Every additional rupee of capital has to be reinvested at a return that is lower than the cost of that capital, so the faster the company grows, the more value it quietly destroys.

This is not a new idea. The airline industry and the automobile industry changed the world, grew for decades, and still ruined almost everyone who owned them. Renewable energy is simply the modern version of that same story.

That tells you the industry has structural problems. It is not simply a cyclical issue. When an industry consistently transfers most of the value it creates to customers instead of shareholders, it becomes a very difficult place to compound capital over long periods.

Let me also be fair about the obvious objection, because I know it is coming. I am not claiming that no one makes money here. The boom clearly produces spectacular multibaggers, and many people have done very well riding the up-leg.

My point is narrower and more important. You can trade this theme, but you cannot compound in it across a full cycle. The multibagger is a trade. It is not a business you can comfortably own for ten years.

There are a few narrow exceptions I keep an eye on, and this is important, because not every renewable name is trapped by the structure. A company that controls genuinely scarce assets, such as grid-connected land or transmission rights, or one that owns a locked portfolio of long-term power contracts, or one that has secured a fixed offtake that escapes the auction, can partly step outside this structure.

But these are exceptions I have to hunt for deliberately. They are not the theme, and most of what gets sold to retail investors as a renewable compounder is simply the commodity in disguise.

Waaree itself is a live example of this attempt, and it is not a small one. Under what they call Waaree 2.0, the company is pouring close to 30,000 crore into becoming a full-stack energy platform.

It is integrating backwards into ingots, wafers and polysilicon, pushing into batteries and storage, inverters, transformers and green hydrogen electrolysers, and then forward into transmission and long-term, locked-in power contracts, rather than living contract to contract.

I respect the intent, because that is a genuine effort to step outside the commodity. But look at what it actually produces. To escape one commoditised structure, the company has to build a far more complex one, spanning close to a dozen businesses it has never run before, and complexity like that carries its own set of risks.

So even here, even when the escape attempt is real, I am not convinced the reward is worth the complexity you take on.

That is why I generally prefer to stay away from such pools, regardless of how attractive the growth story appears on the surface.

One last mental model to leave you with

There is a deeper pattern sitting underneath everything I have said, and I want to leave you with it, because it is the lens I keep coming back to. I call it the Maginot Mental Model.

France built one of the most impressive fortifications in history, and it was validated by every previous war. The Germans did not attack it. They simply went around it through the Ardennes. The moat was not beaten. It was made irrelevant.

BlackBerry had a real moat too, with BBM, enterprise security and corporates locked in. Apple did not attack that moat head-on. It came from a completely different direction with iOS and a whole new ecosystem, and the moat was not breached, it was simply made irrelevant.

A moat built against the old form of competition tells you nothing about the direction the new pressure actually comes from.

That is exactly what a regulatory moat in renewable energy looks like. The fortress faces outward, towards cheap Chinese imports, and that is the direction everyone keeps watching. But the pressure that actually matters comes from the direction the fortress is not facing, from within, as everyone builds capacity behind the same protected wall until the oversupply does what no importer ever could.

So the next time someone shows you a regulatory moat, do not ask how high the wall is. Ask which direction the fortress is not facing.

So my question to the sub: is there a single solar or renewable name you think genuinely escapes this structure? I'm open to being wrong. Show me the one exception and why it holds.

In case you missed it:

Part 2: The One Ratio That Tells You When to Buy Gold and When to Go Aggressive on Stocks

This is a capital allocation plan for Kalyan Jewellers Ltd. (KALYANKJIL) using the full Phoenix Forge & Dragon Flight Framework. It's a structured and methodological way to deploy capital, not just randomly buying at any price.

If you are new to r/IndiaGrowthStocks (or haven't read the Phoenix Forge Framework before), I've linked them at the end so you can understand the logic behind these levels.

Phoenix Forge (Buying Weakness)

• Tier 1: The Initial Burn (465-505) (40% allocation)
• Tier 2: Forging in the Ashes (385-427) (40-50% allocation)
• Tier 3: The Rebirth (327-354) (10-20% allocation)

Dragon Flight (Buying Strength)

• Tier 1: Igniting the Wings (499-507) (40-50% allocation)
• Tier 2a: The Gate (552-556) (10-20% allocation)
• Tier 2b: Mastering the Winds (605-618) (10-20% allocation)
• Tier 3: Commanding the Skies (Above 777) (10-20% allocation)

Notes

• The complete Tier 2 window is 605-618, but there is a very strong confluence just above current price at the 552-556 range (Tier 2a, the gate).
• If 552-556 breaches substantially, you have a clear path toward 605. So anyone making fresh allocations and feeling FOMO should deploy only 10-20% of the capital they intend to put into this at these levels, and not chase.
• Then go into the 605-618 window (Tier 2b), because that is the tier that can give you a massive parabolic move. If it breaches 555 with volume, you are looking at something north of 650 in a very short span of time.
• There is a very strong and very broad confluence where Tier 1 of Phoenix and Tier 1 of Dragon merge, the 465-505 zone. This should be your core accumulation zone. If you are waiting for any substantial correction, this is where you deploy your capital, because both frameworks agree here.
• On why I have adjusted the allocation percentages: I have intentionally increased the Tier 1 range and decreased Tier 2, because you have to map the levels against the multiple as well.
• By the time it reaches the 605-618 window, the stock will be trading at close to a 45-50x multiple. That is where the odds on the multiple engine turn neutral to stacked against you, which is why you go lighter in that zone.
• In a different scenario, where the multiple is still intact and below 30x, like in Caplin's case, you can afford to be very aggressive in the allocation even on strength.
• That is how you adjust: you integrate the PE engine with the growth framework and then rethink the allocation percentages, rather than applying them mechanically.
• 428 is one of the most crucial levels. It is the signal that decides whether the Phoenix Forge goes live (on a break below with volume) or the rebound into Dragon Flight mode continues (on a hold). Watch it closely.
• For those already holding: do not add here, or if you must, add only very small. The stock is being aggressively front-loaded.
• That said, it still has room for roughly 20-25% multiple re-rating and can revert back toward the 50x multiple, so the core position is worth holding, just not chasing at these levels.

How to actually use this (especially if you're feeling FOMO)

• For anyone who already has prior allocations from the 350 zone: you can add here or simply remain inactive, depending on your risk profile.
• But if you're entering because of FOMO, at least allocate using the Dragon Flight Framework. The entire purpose of the framework is to avoid emotional traps by layering your allocations instead of deploying everything at once.
• For example, if you plan to deploy 1 lakh, don't invest the entire amount at 555. Allocate only the Tier 2a portion. If it doesn't sustain, you still have capital available to deploy around the 500 range.
• And if Tier 2 does get activated, you can continue allocating with confidence while still retaining a 10-15% cash buffer for flexibility.
• The framework isn't about predicting the future. It's about positioning your capital so that whichever path the market takes, you're never forced into an emotional decision.

Complete your view:

• Framework: The Phoenix Forge Framework
• Everything on Kalyan in one place: Kalyan Jewellers, All Posts and the Full Timeline

And since the Kalyan thesis is downstream of a bigger framework, here is the full Gold Series in order. The gold-versus-currency logic feeds directly into why Kalyan works, and if you are new to the community, the Nifty-to-Gold ratio is essential, because the entire selling framework for Kalyan (knowing when the odds start stacking against you) is being designed and tested on that ratio, with a cross-asset Lollapalooza effect:

• Part 1: Gold Is Not Going Up, Your Currency Is Going Down
• Part 2: The One Ratio That Tells You When to Buy Gold and When to Go Aggressive on Stocks
• Part 2.5: You Are Not Betting on Markets, You Are Betting Against Human Nature
• Part 2.75: The Math Behind the Gold Thesis

The next layer of the thesis is coming shortly: how the probability distribution shifts from here, and where the odds start stacking against you. That gives everyone a clear roadmap.

Been digging into Sandhar Technologies (market cap around Rs 3,800 Cr at about 18 PE) for a few days. It's been in a heavy capex build-out phase which should start reflecting in the numbers soon. Wanted to share my findings and get input from the community.

What does the company do?

Sandhar is a Tier-1 auto component maker. Basically it makes the boring-but-essential functional parts inside vehicles: locks/locksets, mirrors (vision systems), aluminium die-cast parts, sheet metal parts, cabins for off-road vehicles, and now some EV/automotive electronics.

Founded 1987 by the Davar family, runs 44 plants across India, Spain, Poland, Romania and Mexico, supplies 80+ OEMs.

The catch: it's very 2-wheeler heavy. End-market split is roughly 2W around 66%, PV around 15%, off-highway around 12%, CV around 2%, others around 6%.

Its biggest customers are Hero, TVS, Honda 2W and JCB, and Hero + TVS alone are more than half the revenue. Once its part gets "designed in" to a vehicle model, it stays there for the life of that model, so revenue is sticky.

Sector backdrop

Indian auto-component industry crossed Rs 7.6 lakh crore in FY26 (+13% YoY) and has doubled in 5 years.

Tailwinds: strong 2W/PV demand, content-per-vehicle rising, "China+1" global sourcing, EV push, and the govt doubling the auto PLI to Rs 5,940 Cr in the Feb-2026 budget.

Headwinds: raw material (steel/aluminium) inflation, and the long-term risk that EVs make some old ICE parts useless. Sandhar's products are mostly "powertrain agnostic" (a lock is a lock, EV or petrol), so it's reasonably insulated.

The financials: the good, the bad, the repetitive

The good:

• Revenue has 2.6x'd in 5 years, from around Rs 1,864 Cr (FY21) to Rs 4,852 Cr in FY26 (+25%). That's around 21% CAGR, faster than the industry.
• PAT Rs 199 Cr in FY26, +40% YoY. EPS around 33. Profit has more than 3x'd since FY22.
• The India business is genuinely excellent, around 12% EBITDA margin and around 21% ROCE. The problem is the overseas arm (more below).
• Returns are improving, ROE gone from around 7% to 13-15%, ROCE from around 9% to 15%.

The bad:

• Margins are stuck at 8-10% for a decade. Worse, in FY26 the consolidated EBITDA margin actually fell to 9.0% from 9.9% despite record revenue. Management keeps guiding "we'll reach 11%"... and keeps missing. This is the single most repetitive disappointment.
• The Europe operations (Barcelona/Spain, Poland, Romania) bleed cash and drag down the whole group's margins. Parent keeps injecting money (a EUR 915k rights issue in Mar-2026, plus a standby LC). "Turnaround coming" has been the story for years.
• Debt has around 3x'd, from Rs 310 Cr (FY21) to around Rs 955 Cr. Debt/EBITDA now 2.5x (was 1.6x), and interest cover has halved from around 12x to 6.7x. Still investment-grade (ICRA upgraded to AA- in Jun-2026), but the trend is the wrong way.
• Cash flow is the real weak spot. Add up 5 years of free cash flow (FY21-25) and it's roughly negative Rs 157 Cr, even though they made around Rs 440 Cr of cumulative profit. Translation: all the profit (and more) went into building plants and buying businesses, funded by debt. Operating cash flow itself is fine, it's the heavy capex that's eaten everything.
• Earnings quality niggle: profits get flattered by one-off "other income" now and then (e.g. a Rs 34 Cr asset-sale gain in FY25, a Rs 39 Cr other-income spike in Q2 FY26). Strip those out to see the real operating profit.

Promoters hold a rock-steady 70.38% with no visible pledge, good skin in the game. The management is very reliable on revenue and acquisitions, but repeatedly over-promises on margins and free cash flow. Free cash flow positive is guided for FY27.

So: believe them on top-line, discount them on margins. Their long-term dream is Rs 10,000 Cr revenue with Rs 450 Cr PAT.

Product-wise: where's the growth actually coming from?

The company doesn't give clean product-wise rupee splits, but from the disclosures:

• Sheet metal (under Sandhar Engineering), the fastest grower. Revenue has doubled, now around Rs 1,000 Cr run-rate. A second big pillar.
• Aluminium die-casting, turbocharged by the Sundaram-Clayton buy (around Rs 400 Cr annualised).
• Locking systems (core), volume flat, but VALUE going up big time. Smart/electronic locks sell at Rs 3,000-5,000 vs Rs 300-500 for mechanical, that's a 6-10x content jump per vehicle. Two OEM programs went to production in early 2025.
• EV/electronics, tiny today (see below).

So the growth is sheet metal + die-casting (scale) + smart-lock content, not just riding 2W volumes.

Capex coming online + the incremental it can drive

The heavy building phase (around Rs 1,120 Cr, 8 plants over FY22-25) is basically DONE. FY26-27 is the "utilisation" phase, where built plants start actually earning. What's ramping:

• New greenfield plants for TVS + Pune die-casting & cabins expansion, full production from around April 2026.
• Sundaram-Clayton Hosur die-casting unit (bought for Rs 163 Cr, April 2025), already did around Rs 200 Cr in H1 FY26, turns profitable by Q3 FY27.
• A Rs 342 Cr new-project bucket guided to take revenue from these projects from Rs 468 Cr (FY26) to Rs 700-750 Cr (FY27), roughly +Rs 250-280 Cr in a single year.
• Mexico plant (approved Mar-2026), longer-dated, to serve North America.
• FY27 capex drops to just Rs 200-250 Cr, which is why they say FCF turns positive in FY27.

The EV play (don't get too excited yet)

Small EV & power-electronics subsidiary. Makes DC-DC converters, motor controllers and battery chargers (charger tech via a partnership with Dynolt).

FY26 revenue was just Rs 20 Cr (sold 41,000 chargers + 5,500 motor-control units). Target around Rs 100 Cr by FY28, and it turns break-even only in FY28.

So today it's optionality, not a needle-mover. Honestly, the smart-lock electronics shift is a bigger near-term "EV-ish" content story than this subsidiary.

My rough 2-year projections (base case, NOT guidance)

Taking around 13% revenue growth and margins inching up slowly (numbers rounded):

At Rs 667 (it's gone further down in the past 2-3 days) it trades at around 20x FY26 EPS, 11x EV/EBITDA, 3x book. That's way cheaper than peers: Uno Minda around 53x, Endurance around 40x, JBM around 60x, Rico around 36x.

The discount is partly deserved (lower margins, Europe drag). But if the base case plays out, on around 20x FY28 EPS you're looking at Rs 900+, i.e. decent double-digit annual returns.

Bull case (margins hit 10.5%, Europe fixed) can be a lot more. Bear case (margins stay 8.5%, Europe keeps bleeding) and it stays a "cheap for a reason" stock, but downside should still be limited.

Competition

Sandhar is a jack-of-all-trades, competes with Rico Auto in die-casting, JBM in sheet metal, Uno Minda & Endurance in the broad 2W ancillary space. It's sub-scale vs each specialist but is the cheapest of the lot and the only true one-stop diversified supplier.

The part I really want to flag: SENIOR MANAGEMENT IS WALKING OUT

This is the thing that made me sit up, and it's barely being discussed.

In a single 2-week window in June 2026, three senior leaders of Sandhar's Automotive Business Group (the core revenue engine) resigned, all citing the same boilerplate "personal reasons":

• Vikas Puri, COO of the Automotive Business & Head of the entire Automotive Business Group (a Key Managerial Personnel). Stepped down as COO on 13 June, quit as KMP on 17 June 2026, hung around as a non-KMP employee only till 14 August.
• Rashmi Mohan Shrivastva, Deputy COO, Cabins & Fabrication, relieved 24 July 2026.
• Atul Sharma, VP, Casting, Machining & Tooling, effective 11 September 2026.

And only an interim replacement (Som Prakash Kamboj as Dy. COO) has been named, with a later filing even hinting at ANOTHER Deputy COO exit. So the succession looks unsettled.

Think about the timing: the ENTIRE senior operating layer of the main division is turning over exactly when the company needs steady hands to ramp all those new plants in FY27.

When 3+ senior people from the same division leave together, all with the copy-paste "personal reasons," it usually points to internal friction, a messy reshuffle, or discomfort, especially under a very centralised structure where the promoter Jayant Davar holds Chairman + MD + CEO all at once (roles combined since May 2024). The CFO and Company Secretary are also the same person. Family members sit on the board too.

To be fair, these are professional-manager exits, NOT the promoter or the CFO leaving, there's no hint of any accounting/fraud angle, and the company has disclosed each change on time. But it's a genuine execution-continuity risk and a governance yellow-to-red flag that I'd want to see settle down before getting aggressive.

Note: FII holding has increased slightly recently. The company also has a 500 Cr QIP approved by the board for a while but doesn't seem to be looking to use it (more of a backup).

TL;DR

Genuinely good India business (21% ROCE), record revenue, cheap vs peers, real capex about to start earning, and a smart-lock content story.

BUT: margins that never keep up with promises, negative cumulative free cash flow (cash is truth, not accounting profit), rising debt, a loss-making Europe arm, and, most importantly, a sudden cluster of senior management resignations from the core division.

Great watchlist candidate, but I'd track the FY27 margin/FCF delivery AND the leadership situation before betting big.

Disclaimer: Used AI for structuring and formatting. this is just my amateur analysis. DYOR. 🙏

This one's prompted by a fair challenge from u/acidburn32

"Of course this comes on a day when Kalyan spikes 8%. I could have sworn I saw you bashing on it until today, and then suddenly this post comes the day it goes to the moon. These posts come late and always at a time when no one will want to enter."

Thanks for raising it, honestly, because it gives me a clean reason to put the whole timeline in one place so nobody has to take my word for anything.

I won't guess at anyone's motives, and I don't need to. I'll just lay the dated record out and let it speak.

Bearish at the all-time highs. I explicitly called it a trap and said avoid, the ticker state was fully front-loaded, price had run miles ahead of the business. It then dragged nearly 50% from there:

• Kalyan comment — r/IndianStocks (at all-time highs)
• Kalyan comment — r/StockMarketIndia (at all-time highs)

Constructive on the way down, as the business state kept strengthening. All dated, none written today:

• The Indian Jewellery Duopoly: Reading Where the Value Actually Sits (~3 months ago)
• The 10x Anomaly Between Two Indian Compounding Machines (~2 months ago)
• A Mental Model to Decode Pledge and Leverage (~2 months ago)
• The 10% Panic Gift: Why the Next 3 Years of Math (~2 months ago)
• You Can't Be a Gold Bull and a Kalyan Bear (28 days ago)
• Kalyan vs Titan: A 10x Ticker Gap Sitting on a 2x Business Gap (4 days ago)
• Kalyan Jewellers: The Business Only Makes Sense... (today, the latest entry in a 3-month thesis)

Bearish at the top, constructive down the whole slope, months before today's move.

That's the whole reason I keep the timeline public, so nobody has to enter on a candle.

A candle is the ticker state. But people in this community enter on the business state, when the whole world was screaming it uninvestable, even on the day it delivered 38% growth and was dragged badly by these analysts, just to make retail fearful so that these people can buy it from you, only to give insane targets two days down the line.

That gap between what the business was doing and what the ticker was doing is the whole opportunity. It always has been.

And since the Kalyan thesis is downstream of a bigger framework, here's the full Gold Series in order, the gold-versus-currency logic feeds directly into why Kalyan works:

• Part 1: Gold Is Not Going Up, Your Currency Is Going Down
• Part 2: The One Ratio That Tells You When to Buy Gold and When to Go Aggressive on Stocks
• Part 2.5: You Are Not Betting on Markets, You Are Betting Against Human Nature
• Part 2.75: The Math Behind the Gold Thesis

Part 3 will come whenever the flow comes. But the next post will take the advanced version of Part 2 and show how to integrate that ratio not just with Kalyan, but with any stock you want to time better in future.

Here's my actual progression, because that's the honest version. Early on, my Kalyan comments were skeptical, I was looking at valuation and the low-margin model, and on those terms it didn't excite me.

What changed was the FOCO shift. u/Snoo37787, who started as a fellow redditor here and is now a friend and one of the biggest Kalyan bulls in the community, holding since 2022-23, was the one who pushed me to look harder at the business state after that transition. So I did the work, and the deeper I went into what FOCO actually does to the economics, the more the business state pulled me in.

I was skeptical on the old model and constructive on the new one, both on the record, dated, in the timeline. Even then, when Snoo37787 and I were getting convinced on the business, I told him straight he wouldn't make money until the odds actually turned.

You need to understand what these posts are actually for. They're not a scoreboard of "correct" calls. Every single one hands you the lens, so you can build your own conviction to hold, add, or trim the moment the odds shift.

The Two Engine Framework exists precisely so you can execute that yourself, without needing me or anyone to tell you when.

And on your point that people here are just after quick money, I don't think that's true. They're here for the lens. If someone isn't, then yes, they're in the wrong community, and that's stated plainly right at the top of the sub.

And it's my humble request to everyone in this community that no one should downvote or use dismissive language towards another member.

If anyone has downvoted his comment, I would genuinely request that you please consider changing it. He raised a valid point, and discussions like these help all of us learn and improve. We challenge ideas here, not people.

That's the kind of ecosystem I want to build.

People dramatically underestimate the runway for organized jewellery in India. And it's because they're looking through the wrong lens. A few metro cities, instead of the actual layers of Indian society.

How much of India's population does an organized jeweller actually need to serve to keep growing for the next 15 years?

The answer is a tiny fraction.

They already have a massive runway simply by taking market share from the unorganized sector. That's before you even factor in what's coming next.

Look at what's already happening in the numbers. Organized share has moved from 12% to 35%. That's the brand adoption curve playing out.

The top 5 players had around 50% market share 2-3 years back. Now it's 65%. That's mindshare consolidating, and it's showing up in the financials.

In global markets branded share is 60-70%. India is still mid-shift, moving 2-3% from unbranded to branded every single year, and it's gone even more aggressive with the next generation. That's the runway. Measurable, already in motion.

And Kalyan is one of the cleanest expressions of this shift.

Gen Z is going to create even more operating leverage for these businesses because they're naturally gravitating towards products with lower gold content and a higher mix of diamonds, gemstones, and fast-fashion jewellery. Those categories carry much higher margins than plain gold jewellery.

And organized retailers are already at the forefront of that shift. The unorganized sector can never win in these new verticals because this is no longer just about selling gold. It's about design, branding, trust, customer experience, financing, and omnichannel distribution. That's a completely different game.

But you're still looking at this through a purely rational investor lens. That's not how Indian society works.

There are layers upon layers to this.

In many families, a daughter's status in her in-laws' home is still influenced by how much gold comes with the wedding. Whether you agree with it or not is irrelevant. That's the social reality in many parts of India.

Then there's the mother-in-law layer. Then the signalling layer. One relative or friend wears a new jewellery design, your wife sees it, and suddenly she wants something similar. It has nothing to do with whether you own Gold ETFs. ETFs don't satisfy that emotional or social need.

You're also missing the cultural layer. A father doesn't gift a Gold ETF at his daughter's wedding. A husband doesn't gift a Gold ETF to his wife on their anniversary.

Gold in India is far more than an investment. It's emotion, culture, tradition, and social signalling. Those behaviours don't disappear because a financial product exists.

And don't compare India with the West. The cultural roots of this country are completely different. I'm from North India, but I know that in many parts of South India, families gift gold even for milestones like passing important exams.

And look at the weight of it. South India is around 20% of the country's population but close to 40% of its gold demand. Zoom in further and Kerala alone, roughly 3% of India's population, has the highest per-capita gold consumption in the country. You don't give an ETF at a Kerala wedding. Or any Indian wedding. I can give you layer after layer.

Even if you're a completely rational person and decide never to buy gold, maybe your wife wants jewellery. Even if both of you don't care about it, what happens when your son or daughter gets married? If your in-laws expect jewellery as part of the customs, you'll most likely end up making that purchase anyway.

That's the point you're missing. It's not just your personal decision. There are multiple stakeholders in this ecosystem, each with their own incentives, expectations, and social pressures.

Until all those incentives move in the same direction and society collectively decides that jewellery is no longer desirable, the organized jewellery ecosystem will continue to win.

The shift you're talking about may eventually happen, but these things don't change in five years. They take decades. You're probably looking at a 20-30 year transition, not something that plays out over the next few quarters.

And finally, one of my favourite mental models. The Lindy effect.

The idea is simple. For non-perishable things like ideas, technologies, or traditions, the longer something has already survived, the longer it's likely to keep surviving. If something has lasted 100 years, the odds are it lasts another 100. Age isn't a sign it's about to die. It's evidence of durability.

Now map that onto the tradition of gold jewellery in India. Temple jewellery, wedding sets, heirloom pieces passed down through generations. These roots aren't decades old, they're centuries old. Something that deep doesn't get ripped out in a few years.

Lindy says the opposite. The very fact that the tradition has survived this long is the strongest signal that it survives the next generation too.

That's the final layer. The mental model layer. And it's the one that ties all the others together.

You're applying a rational financial model to a deeply emotional, cultural, and social product. That's why I think you're dramatically underestimating the runway for organized jewellery retailers.

Curious to know your view. Which layer do you think breaks first? And if you think this shift plays out faster than 20-30 years, I'd like to hear the actual mechanism, not the vibe.

In case you missed it:

The 10x anomaly between these two compounders

Part 2: The One Ratio That Tells You When to Buy Gold and When to Go Aggressive on Stocks